Spirometry Normal Values: A Complete Guide to Reference Values, Lung Function, and Obstructive Lung Disease

Spirometry normal values provide an important reference for assessing lung function, evaluating respiratory symptoms, and identifying abnormalities in the movement of air through the lungs. Spirometry is a widely used pulmonary function test that measures how much air a person can forcibly exhale and how quickly the air leaves the lungs. These measurements provide objective information that supports the assessment of breathing difficulties, persistent cough, wheezing, and suspected lung disease. They are particularly useful in evaluating conditions such as asthma and chronic obstructive pulmonary disease (COPD), in which airflow obstruction may affect the amount of air exhaled during specific periods of the test. However, spirometry findings must be interpreted alongside the patient’s symptoms, clinical history, and other relevant investigations rather than being treated as a diagnosis in isolation.

Three measurements are central to understanding spirometry results: forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and the FEV1/FVC ratio. FVC represents the total volume of air forcibly exhaled after a full inhalation, while FEV1 measures the volume exhaled during the first second of that maneuver. The ratio compares these two measurements and helps determine whether airflow obstruction is present. Although these values are essential for interpreting lung function, their expected ranges vary between individuals. Age, height, sex, and the reference equations used to calculate predicted values influence how a person’s measurements should be assessed. Consequently, spirometry normal values should be understood in relation to appropriate reference values rather than as a single set of numbers that applies to everyone.

Accurate interpretation also depends on the quality of the spirometry test. A patient who does not inhale fully, exhales with insufficient effort, stops prematurely, or performs the maneuver inconsistently may produce results that do not accurately reflect their lung function. Healthcare professionals therefore assess the acceptability and repeatability of the measurements before drawing conclusions. They also distinguish between obstructive and restrictive patterns, recognize results that fall outside the expected reference range, and consider whether additional pulmonary function testing is necessary. For example, a reduced FEV1/FVC ratio may indicate airflow obstruction, whereas a reduced FVC with a preserved ratio may suggest a restrictive pattern. However, a low FVC alone cannot confirm restrictive lung disease; measurement of total lung capacity is generally needed to establish whether true restriction is present.

Understanding spirometry normal values involves more than memorizing reference ranges. It requires knowledge of the measurements obtained during testing, the equations used to establish expected values, and the clinical factors that influence interpretation. This includes understanding how to prepare for and perform a spirometry test, evaluate the reliability of its measurements, interpret normal and abnormal results, and recognize patterns associated with common respiratory conditions. These principles help clinicians distinguish expected variation from potentially significant abnormalities and determine when further assessment may be appropriate. By connecting spirometry measurements with their physiological and clinical significance, it becomes easier to understand how pulmonary function testing contributes to respiratory assessment, disease evaluation, and ongoing monitoring of lung health.

Spirometry Test Basics and Clinical Purpose

Spirometry is a fundamental pulmonary function test used to evaluate how effectively the lungs move air during breathing. It provides objective measurements of the volume of air a person can exhale and the speed at which the air moves out of the lungs during a forced breathing maneuver. These measurements help clinicians assess respiratory symptoms, identify patterns that may indicate airflow obstruction, and monitor changes in lung function over time. According to the American Thoracic Society (ATS) and European Respiratory Society (ERS), spirometry is an important tool for evaluating lung disease, monitoring disease progression, and assessing responses to treatment. 

Unlike a physical examination, which may reveal signs such as wheezing, rapid breathing, or reduced breath sounds, a spirometry test produces numerical measurements that can be compared with appropriate reference values. This helps clinicians determine whether a person’s breathing measurements fall within the expected range or suggest an abnormality that requires further investigation. For example, a person experiencing persistent shortness of breath may have spirometry performed to investigate suspected asthma or chronic obstructive pulmonary disease (COPD). The results can help establish whether airflow is limited, although they must be interpreted alongside symptoms, medical history, and other clinical findings.

Understanding spirometry normal values requires familiarity with the purpose of the test, the equipment used, and the physiological information obtained. The principal measurements include forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and the relationship between these values. Together, they provide information about how much air can be forcibly exhaled and whether it leaves the lungs at an expected rate. However, spirometry does not measure every aspect of respiratory function. For example, it does not directly measure total lung capacity or the efficiency of oxygen transfer from the lungs into the bloodstream. Additional pulmonary function tests may be necessary when clinicians need this information.

How a Spirometer Measures Lung Function

A spirometer is a device that measures airflow or the volume of air moving into and out of the lungs. During a standard spirometry test, the person usually takes a deep breath until the lungs are filled as fully as possible and then exhales into a mouthpiece as forcefully and completely as instructed. The spirometer records the resulting airflow and volume over time, producing measurements that help assess lung function. Depending on the equipment, the test may also record the inspiratory phase after forced expiration, providing additional information about the quality of the maneuver. 

The measurements are generated through a coordinated process involving the patient’s breathing effort, the movement of air through the airways, and the spirometer’s recording system. Because results depend on both physiology and technique, the person performing the test must explain the maneuver clearly, observe the patient’s effort, and assess the quality of the recorded data.

The basic process involves the following steps:

1. Full inspiration: The person inhales deeply to bring the lungs close to their maximum volume. Starting from a full inhalation is important because an incomplete breath can reduce the volume measured during expiration.
2. Forceful expiration: The person exhales rapidly and forcefully into the mouthpiece. The initial effort is particularly important for measuring how much air can be expelled during the first second.
3. Continued expiration: The person continues exhaling until the maneuver is complete, allowing the spirometer to record the total volume expelled.
4. Recording and quality assessment: The device displays or stores measurements, which are reviewed to determine whether the maneuver was performed adequately and whether the results are sufficiently consistent for interpretation.

The main measurements obtained during this process include:

• Forced vital capacity (FVC): The total volume of air forcibly exhaled after a full inhalation.
• Forced expiratory volume in one second (FEV1): The volume of air expelled during the first second of the forced expiration.
• FEV1/FVC ratio: The proportion of the forced vital capacity exhaled during the first second. This ratio is particularly useful when assessing airflow obstruction.

These measurements have different clinical meanings. For example, FVC describes the total volume expelled during the maneuver, while FEV1 reflects how much air can be expelled in the initial second. If the airways are narrowed, a person may exhale a smaller proportion of the total volume during that first second, reducing the FEV1/FVC ratio.

Consider a hypothetical example in which a person has an FVC of 4.0 liters and an FEV1 of 3.2 liters. The FEV1/FVC ratio is calculated by dividing FEV1 by FVC:

\[ \frac{3.2}{4.0}\times100=80\% \]

The result means that the person exhaled 80% of their measured forced vital capacity during the first second. However, this percentage should not be interpreted in isolation. Whether it is normal depends on the person’s appropriate reference values and the lower limit of normal. A ratio that appears reasonable numerically may still be abnormal for a particular individual, while a reduced ratio may indicate airflow obstruction that requires clinical evaluation.

A spirometer may display measurements as numerical values, graphs, or both. Common graphical displays include the volume-time curve, which shows how the volume of air exhaled changes over time, and the flow-volume loop, which illustrates airflow at different lung volumes. These curves help clinicians identify an incomplete maneuver, inconsistent effort, or patterns that may support further assessment. A device can calculate measurements automatically, but automated output does not replace quality assessment or professional interpretation.

An important distinction is that spirometry measures air movement rather than every component of lung function. Although the test provides useful information about airflow and the volume exhaled, it does not directly measure the total amount of air remaining in the lungs after maximal expiration. Consequently, a reduced FVC may suggest a restrictive pattern, but confirming restrictive lung disease generally requires a separate measurement of total lung capacity. Similarly, spirometry findings alone may not establish the precise cause of an abnormal result.

Indications for a Pulmonary Function Test

A pulmonary function test is requested when objective information about breathing and lung performance is needed. Spirometry is one of the most commonly used pulmonary function tests because it helps evaluate respiratory symptoms, investigate suspected lung disease, and monitor the effects of treatment. The decision to perform spirometry depends on the person’s symptoms, risk factors, medical history, and the clinical question that needs to be answered. 

The main indications for spirometry include the following.

1. Investigating respiratory symptoms

Spirometry is often indicated when a person experiences persistent or unexplained respiratory symptoms. These may include:

• Shortness of breath (dyspnea): Difficulty breathing during physical activity or at rest may indicate impaired airflow or another respiratory problem.
• Persistent cough: Spirometry may help investigate chronic cough, particularly when asthma or another airway disorder is suspected.
• Wheezing: A whistling sound during breathing may occur when the airways become narrowed. Spirometry helps determine whether airflow obstruction is present.
• Reduced exercise tolerance: Breathlessness or fatigue during ordinary activities may prompt an assessment of lung function.
• Chest tightness associated with breathing difficulties: When asthma is suspected, spirometry can provide objective evidence of variable airflow limitation.

For example, a person who experiences recurrent wheezing at night and shortness of breath during exercise may undergo spirometry to investigate possible asthma. The results may demonstrate airflow obstruction or show improvement after administration of a bronchodilator. However, normal spirometry at one appointment does not necessarily exclude asthma, because airflow limitation can vary over time.

2. Assessing suspected obstructive lung disease

Spirometry plays an important role in evaluating obstructive lung disease, particularly asthma and chronic obstructive pulmonary disease (COPD). These conditions affect airflow through the respiratory system, although their underlying mechanisms and clinical presentations differ.

In asthma, airway inflammation and narrowing can cause variable airflow limitation. In COPD, persistent airflow obstruction is commonly associated with chronic exposure to harmful particles or gases, particularly tobacco smoke, and may involve airway abnormalities and damage to lung tissue.

Spirometry helps assess whether the FEV1/FVC ratio is reduced relative to the appropriate lower limit of normal. When COPD is suspected, post-bronchodilator spirometry is important for confirming persistent airflow obstruction within the appropriate clinical context. Asthma assessment may also include bronchodilator responsiveness testing, alongside symptoms and other evidence of variable airflow limitation.

3. Investigating suspected restrictive lung disease

A pulmonary function test may be indicated when symptoms, imaging findings, or other clinical information raise concerns about restrictive lung disease. Conditions such as pulmonary fibrosis can reduce the lungs’ ability to expand normally, resulting in reduced lung volumes.

Spirometry may reveal a reduced FVC with a preserved or increased FEV1/FVC ratio, suggesting a possible restrictive pattern. However, this pattern is not sufficient to confirm restriction because other factors, including incomplete exhalation and air trapping, can also reduce FVC.

When restriction is suspected, clinicians may request additional lung volume measurements to determine whether total lung capacity is below the expected range. Other investigations, such as diffusion capacity testing and chest imaging, may be appropriate depending on the suspected condition.

4. Monitoring diagnosed respiratory conditions

Spirometry is useful after a respiratory condition has been diagnosed because it allows clinicians to compare measurements over time. Repeated testing can help assess disease progression, treatment response, and changes in respiratory function.

Examples include:

• Monitoring lung function in a person with COPD to identify significant changes over time.
• Assessing airflow and treatment response in a person with asthma.
• Evaluating lung function in selected patients with interstitial lung disease.
• Reassessing respiratory function after an exacerbation when clinically appropriate.

For meaningful comparison, the tests should be performed with appropriate technique and quality standards. Changes in FEV1 or FVC should be considered alongside symptoms, medication use, recent illness, and other clinical findings. A single change does not automatically mean that a disease has progressed or that treatment has failed.

5. Evaluating treatment effectiveness

A pulmonary function test may be performed before and after a bronchodilator to assess whether airflow measurements improve following medication administration. This is known as bronchodilator responsiveness testing.

For example, a person with suspected asthma may undergo spirometry before receiving a prescribed bronchodilator and repeat the maneuver afterward. An improvement in FEV1 or FVC may support the presence of variable airflow limitation. The interpretation depends on established criteria, test quality, and the clinical context; a positive response does not establish asthma on its own, and a negative response does not necessarily exclude it.

Spirometry can also help evaluate changes following other respiratory treatments. However, medication decisions should not be based on spirometry measurements alone.

6. Assessing respiratory health before surgery

Spirometry may be considered when a patient has respiratory symptoms, known lung disease, or other clinical concerns that could affect perioperative management. The findings may help clinicians assess respiratory impairment and plan appropriate care.

However, routine spirometry is not necessary for every person undergoing surgery. Its use should be guided by the patient’s history, symptoms, examination findings, type of procedure, and whether the results are likely to influence management.

7. Evaluating occupational and environmental exposure

People exposed to respiratory hazards, such as occupational dust, chemical fumes, or other inhaled irritants, may require spirometry as part of an appropriate health surveillance program. Serial measurements can help identify changes in lung function that warrant further assessment.

For instance, a worker with prolonged exposure to industrial dust may undergo periodic spirometry according to an occupational health program. A decline in measurements may prompt a review of exposure, symptoms, workplace controls, and the need for further clinical investigation. Spirometry can identify functional changes, but it cannot independently establish that an occupational exposure caused them.

8. Assessing changes in lung function over time

Spirometry may be used when clinicians need to establish a baseline or compare current respiratory function with earlier measurements. This can be relevant in chronic respiratory disease, selected occupational settings, and conditions or treatments associated with potential pulmonary complications.

The interpretation of serial spirometry requires attention to measurement quality, the interval between tests, and the magnitude of change. Comparing results obtained under substantially different testing conditions can lead to misleading conclusions.

In general, spirometry is most useful when there is a clear clinical reason for performing it and the results can inform assessment, monitoring, or management. It is not a complete substitute for other investigations, and it should not be used as an indiscriminate screening test in people without symptoms or a relevant risk profile. The ATS/ERS standards emphasize that spirometry findings contribute to diagnosis when interpreted alongside the patient’s history, symptoms, and other clinical evidence.

Key Spirometry Measurements

Interpreting spirometry normal values begins with understanding the measurements that describe how much air a person can exhale and how quickly it moves through the airways. Three measurements are particularly important in routine spirometry: forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and the FEV1/FVC ratio. Each provides different information about pulmonary function, and their combined interpretation helps clinicians identify patterns that may indicate normal lung function, airflow obstruction, or a possible restrictive impairment.

The American Thoracic Society (ATS) and European Respiratory Society (ERS) emphasize that spirometry measurements should be assessed against appropriate reference values and interpreted in the context of test quality and clinical findings. A number displayed by a spirometer does not automatically establish whether lung function is normal or abnormal. The patient’s measured values must be compared with the expected range for an appropriate reference population, taking relevant physiological factors into account. 

For example, two people may have different FVC and FEV1 values because they differ in height, age, and other factors that influence lung size and respiratory function. A larger absolute volume does not necessarily indicate healthier lungs, just as a smaller volume does not automatically indicate lung disease. The relationship between measurements, their position relative to the lower limit of normal, and the quality of the spirometry test are more informative than an isolated number.

Forced Vital Capacity (FVC)

Forced vital capacity (FVC) is the total volume of air a person can forcibly exhale after taking the deepest possible breath. It is usually measured in liters during a spirometry test. To obtain this measurement, the person inhales fully and then exhales as forcefully and completely as possible through a mouthpiece connected to a spirometer. The device records the volume of air expelled during the maneuver.

FVC provides information about the amount of air expelled during a forced expiration. It is one of the principal measurements used when assessing spirometry normal values, but it should not be confused with the total amount of air contained in the lungs. Some air normally remains in the lungs even after maximal expiration, and conventional spirometry does not measure that residual volume directly.

How FVC is measured and interpreted

The FVC measurement depends on a sufficiently deep initial inhalation, a forceful start to expiration, and continued exhalation until the maneuver is complete. If a person stops too early, does not inhale fully, or experiences difficulty performing the test, the recorded FVC may be lower than the person’s true capacity.

Once an acceptable measurement has been obtained, the result is compared with an appropriate predicted value derived from reference equations. These equations estimate the expected measurement for a person with relevant characteristics, including age, height, and biological sex, using a suitable reference population. The lower limit of normal (LLN) helps identify results that are unusually low relative to that population. A value below the LLN is generally considered below the expected range, whereas a value within the reference range is not automatically proof that every aspect of lung function is normal. 

For example, consider two hypothetical adults whose FVC measurements are 3.0 L and 4.5 L, respectively. It would be inappropriate to conclude that the second person has better lung function simply because the measured volume is higher. If the first person’s result falls within the expected range for their age and height, while the second person’s result is below their predicted range, the interpretation could be quite different from what the absolute volumes suggest.

What a reduced FVC may indicate

A reduced FVC means that the measured volume of air forcibly exhaled is lower than expected. Several explanations are possible, and the result must be interpreted alongside the FEV1/FVC ratio and other clinical information.

• Possible restrictive impairment: Conditions that limit lung expansion, including pulmonary fibrosis, may reduce FVC. However, spirometry alone cannot confirm restrictive lung disease.
• Air trapping associated with airflow obstruction: In obstructive conditions, some air may remain trapped in the lungs during expiration, reducing the volume that can be forcibly exhaled.
• Incomplete expiration or suboptimal effort: A person who stops exhaling too early or does not perform the maneuver correctly may produce an artificially low FVC.
• Respiratory muscle weakness or chest wall limitations: Conditions that impair the muscles involved in breathing or restrict chest movement can affect the volume exhaled.

A reduced FVC with a normal or increased FEV1/FVC ratio may suggest a restrictive pattern. Confirmation generally requires measurement of total lung capacity (TLC). If the FEV1/FVC ratio is also reduced, clinicians may need lung volume testing to determine whether obstruction alone or a combination of abnormalities explains the findings. 

FVC is therefore most useful when considered together with other spirometric measurements. It helps describe the volume expelled during forced expiration, but it cannot independently distinguish every cause of reduced lung volume or establish a specific respiratory diagnosis.

Forced Expiratory Volume in One Second (FEV1)

Forced expiratory volume in one second (FEV1) is the volume of air a person can forcibly exhale during the first second of expiration after taking a full breath. It is measured in liters and is one of the most important indicators of expiratory airflow in a spirometry test. While FVC describes the total volume expelled during the forced maneuver, FEV1 focuses on how much air leaves the lungs during the initial second, when expiratory airflow is normally greatest.

FEV1 is particularly useful when assessing obstructive lung disease, including asthma and chronic obstructive pulmonary disease (COPD). In these conditions, narrowing of the airways, increased airway resistance, reduced elastic recoil, or premature airway closure may limit the rate at which air can be expelled. As a result, FEV1 may be reduced, although its interpretation depends on the FVC measurement, the FEV1/FVC ratio, and the appropriate reference range.

How FEV1 is measured

During spirometry, the person inhales as deeply as possible and then exhales forcefully into the spirometer. The device records the volume expelled during the first second of the maneuver. Obtaining a reliable FEV1 requires a rapid, forceful start to expiration and a technically acceptable test. Hesitation at the beginning, coughing during the first second, or inconsistent effort can affect the measurement.

The recorded value is compared with a predicted value calculated using appropriate reference equations. Because expected lung function varies between individuals, the same absolute FEV1 measurement may have different clinical meanings for different people. Clinicians therefore consider whether the result falls below the lower limit of normal rather than relying on a single universal volume.

Clinical significance of FEV1

FEV1 provides information about expiratory airflow and the degree of functional impairment, but it should not be interpreted independently of other measurements.

• Reduced FEV1: A low value may occur with airflow obstruction, restrictive impairment, respiratory muscle weakness, or inadequate testing effort. The accompanying measurements help clarify the possible explanation.
• FEV1 within the reference range: This indicates that the measured volume is not unusually low for the selected reference population. However, a normal FEV1 alone does not exclude early respiratory disease or every form of abnormal lung function.
• Changes over time: Comparing technically acceptable measurements from different appointments can help clinicians monitor lung function in people with established respiratory conditions.

For example, a patient with COPD may have a reduced FEV1 because narrowed airways make it difficult to expel air rapidly. Repeated spirometry can help assess changes in lung function, although results must be considered alongside symptoms, exacerbations, medication use, and other clinical findings.

FEV1 is also useful when evaluating responses to bronchodilator medication. If airflow improves after a bronchodilator, FEV1 may increase, indicating a change in expiratory performance. However, the significance of that change must be assessed using the applicable interpretation criteria. A response to bronchodilator medication does not, by itself, establish a diagnosis of asthma or distinguish asthma conclusively from COPD.

The relationship between FEV1 and FVC is essential because a reduced FEV1 does not automatically mean that airflow obstruction is present. Both measurements may decrease in restrictive impairment, for example, while their ratio remains within the normal range. For this reason, FEV1 is interpreted alongside FVC and the FEV1/FVC ratio to identify the physiological pattern most consistent with the results. 

FEV1/FVC Ratio

The FEV1/FVC ratio expresses the proportion of the total forced vital capacity exhaled during the first second of expiration. It is calculated by dividing FEV1 by FVC. Unlike FEV1 and FVC, which are expressed as volumes in liters, the ratio is generally reported as a decimal or percentage.

The ratio is especially important for identifying airflow obstruction. When the airways are narrowed, the amount of air exhaled during the first second often decreases disproportionately compared with the total volume that can eventually be expelled. This causes the FEV1/FVC ratio to fall.

How to calculate the FEV1/FVC ratio

The formula is:

\[ \text{FEV}_1/\text{FVC} =\frac{\text{FEV}_1}{\text{FVC}}\times100 \]

Consider a hypothetical spirometry test with the following measurements:

Forced expiratory volume (FEV1)

3.0 L

Forced vital capacity (FVC)

4.0 L

FEV1/FVC ratio

75%

\[ \frac{3.0}{4.0}\times100=75\% \]

This result means that 75% of the measured FVC was expelled during the first second. Whether that ratio is normal depends on the person’s appropriate reference values and lower limit of normal. A ratio of 75% may be within the expected range for one person but below the expected range for another.

Interpreting a low FEV1/FVC ratio

A ratio below the lower limit of normal indicates an obstructive spirometric pattern when the test is technically acceptable. The LLN is commonly defined by the fifth percentile of the relevant healthy reference population. This approach accounts for expected variation with age and other characteristics rather than applying the same threshold to everyone.

A low ratio may be seen in:

• Asthma: Variable airway narrowing and inflammation can reduce the proportion of air exhaled during the first second.
• Chronic obstructive pulmonary disease (COPD): Persistent airflow obstruction can reduce the ratio, particularly when assessed after bronchodilator administration for diagnostic purposes.
• Other obstructive airway conditions: Certain diseases affecting the airways can also produce an obstructive pattern.

A reduced ratio identifies a physiological abnormality; it does not determine the underlying disease on its own. Clinical history, symptoms, exposure history, and additional investigations may be needed to establish the diagnosis.

Interpreting a normal or increased ratio

A ratio within the reference range generally indicates that airflow is not disproportionately reduced relative to the total forced volume. If both FEV1 and FVC are also within their expected ranges and the test is technically satisfactory, the results may be consistent with normal spirometry.

However, a normal or increased ratio does not automatically establish that all aspects of lung function are normal. For example, restrictive lung disease may reduce FEV1 and FVC proportionately, preserving the ratio. A reduced FVC with a preserved ratio may therefore warrant further assessment, including measurement of total lung capacity when restriction is suspected.

It is also important to distinguish the physiological interpretation standard from disease-specific diagnostic criteria. The 2022 ATS/ERS interpretive standard generally favors the lower limit of normal for identifying an abnormal FEV1/FVC ratio. COPD guidelines, including those from the Global Initiative for Chronic Obstructive Lung Disease (GOLD), use a post-bronchodilator FEV1/FVC ratio below 0.70 as part of their diagnostic criteria. These approaches serve related but distinct purposes, and the applicable clinical guideline should be followed. 

Together, FVC, FEV1, and the FEV1/FVC ratio provide the foundation for interpreting spirometry measurements. FVC describes the total volume forcibly exhaled, FEV1 measures the volume expelled during the first second, and their ratio helps identify airflow obstruction. Accurate interpretation requires all three measurements to be considered alongside appropriate reference values, test quality, and the patient’s clinical presentation.

Normal Spirometry Values and Reference Equations

Normal spirometry values are used to determine whether measurements obtained during a spirometry test fall within the range expected for a person with similar physiological characteristics. Because lung size, airway dimensions, and respiratory function vary naturally between individuals, there is no single FVC or FEV1 value that is normal for everyone. Instead, clinicians compare measured results with predicted values calculated from validated reference equations and assess whether the measurements fall within the expected range.

The Global Lung Function Initiative (GLI) has developed widely used reference equations for interpreting spirometry measurements across a broad age range. The 2022 ERS/ATS technical standard on lung function interpretation discusses the use of appropriate reference equations, lower limits of normal, and z-scores to distinguish expected variation from potentially abnormal findings. The choice of reference equation matters because an identical measurement can be classified differently depending on the equation used. 

Understanding these principles is essential when evaluating spirometry normal values. A result that appears low in absolute terms may be normal for one individual, while a result that appears reasonable may fall below the expected range for another. Interpretation therefore involves more than checking whether a measurement exceeds a fixed numerical cutoff. It requires consideration of the predicted value, the range of expected measurements, the quality of the test, and the patient’s clinical circumstances.

Predicted Values by Age, Height, and Sex

Predicted values are estimates of the lung function measurements expected in a healthy person with particular characteristics. They are calculated using reference equations developed from measurements collected from healthy populations. For spirometry, these equations commonly account for age, height, and biological sex, which are major determinants of expected FVC, FEV1, and the FEV1/FVC ratio. Depending on the selected reference system, population characteristics and ancestry may also be considered. 

Predicted values do not represent a person’s individually measured lung capacity. Rather, they provide a statistical estimate against which the observed measurement can be compared. This distinction is important because healthy individuals with similar characteristics may still have different spirometry results.

How age influences spirometry values

Age affects lung function throughout life. During childhood and adolescence, the lungs and airways grow, and FVC and FEV1 generally increase as body size increases. In adulthood, lung function follows a different pattern, with changes associated with aging, including gradual reductions in expiratory airflow and changes in lung and chest wall mechanics.

Consequently, the expected FEV1/FVC ratio is not identical across all age groups. A ratio that is typical for a younger adult may be below the expected range for an older child or adult, while a fixed cutoff may fail to identify an abnormal result in a younger person. Reference equations account for these age-related patterns more accurately than a single universal threshold.

For example, consider two people with the same measured FEV1/FVC ratio but different ages. The ratio may fall within the expected range for one person and below the lower limit of normal for the other. The correct interpretation depends on comparing each result with the appropriate reference values rather than assuming that both measurements have the same clinical meaning.

How height influences predicted values

Height is strongly associated with lung size. Taller individuals generally have larger expected FVC and FEV1 values than shorter individuals of the same age and biological sex. Reference equations incorporate measured standing height to estimate the expected lung volumes and airflow measurements.

Accurate height measurement is therefore important when performing a spirometry test. Entering an incorrect height into the spirometer can produce an inappropriate predicted value and potentially lead to an incorrect interpretation. For example, if a person’s height is entered as substantially taller than their actual height, the predicted FVC and FEV1 may be higher than appropriate, making otherwise acceptable measurements appear reduced.

How biological sex affects reference values

Reference equations also account for differences in average lung volumes and airflow measurements associated with biological sex. These differences reflect population-level physiological patterns, including differences in lung and airway size relative to body height. The equations use these characteristics to estimate expected measurements rather than treating the same absolute FVC or FEV1 as normal for everyone.

Biological sex is a statistical input in many established reference equations; it does not determine an individual’s lung function with certainty. A person’s results must still be interpreted using their measured values, relevant clinical information, and the reference system selected by the testing service.

The role of reference equations and the GLI

Reference equations are developed by analyzing lung function measurements from healthy individuals and modeling the relationship between those measurements and relevant characteristics. The Global Lung Function Initiative developed equations intended to support consistent interpretation across a wide age range, including children and adults. The GLI 2012 equations introduced multi-ethnic reference values for spirometry, while the GLI 2022 equations introduced race-neutral spirometry reference equations. The appropriate equation depends on the applicable clinical standards, population, and local guidance. 

A spirometry report should identify the reference equation used. This allows clinicians to understand how predicted values were calculated and helps maintain consistency when comparing measurements across different appointments or testing facilities.

Lower Limit of Normal and Reference Ranges

The lower limit of normal (LLN) is the threshold used to identify spirometry measurements that are lower than expected for a healthy person with comparable characteristics. It is generally defined as the fifth percentile of the appropriate healthy reference population, corresponding to a z-score of approximately −1.645. This means that about 5% of healthy individuals may have measurements below the LLN even when they do not have respiratory disease. For this reason, an abnormal result should be interpreted alongside symptoms, medical history, test quality, and other clinical findings. 

The reference range describes the distribution of measurements expected in a healthy population. For spirometry, clinicians commonly assess whether FEV1, FVC, and the FEV1/FVC ratio fall within their respective expected ranges. The LLN is particularly important because a measurement can be below the population average without being abnormally low. Similarly, a value that appears close to the average may still fall below the LLN in a particular individual, depending on the reference equation and the variability of the measurement.

Understanding the lower limit of normal in practice

The LLN helps clinicians distinguish expected physiological variation from results that warrant further investigation. Its application depends on the measurement being assessed:

• FEV1: A value below the LLN indicates that the volume of air exhaled during the first second is lower than expected.
• FVC: A value below the LLN indicates that the total volume forcibly exhaled is lower than expected. This can occur for several reasons and does not independently confirm restrictive lung disease.
• FEV1/FVC ratio: A ratio below the LLN indicates an obstructive spirometric pattern, provided the test is technically acceptable.

Consider a hypothetical patient whose FEV1 is slightly below the predicted average but remains above the LLN. The result may still fall within the expected reference range. Another patient with a similar absolute FEV1 might have a value below the LLN because their predicted lung function is different. These examples demonstrate why interpreting spirometry results requires more than comparing measurements with an average value.

Z-scores and the interpretation of normal ranges

A z-score describes how far an observed measurement lies from the predicted distribution, accounting for the variability expected in the reference population. A z-score of zero corresponds approximately to the predicted median, while a negative score indicates a value below that median.

For routine interpretation, the fifth percentile, corresponding to a z-score of approximately −1.645, is commonly used as the LLN. A result below this threshold is considered unusually low relative to the reference population. The z-score approach is useful because it accounts for age-related and other differences in variability, rather than assuming that every person has the same acceptable percentage of the predicted value. 

Why 80% of predicted is not a universal definition of normal

Historically, spirometry results were often considered normal when FEV1 or FVC reached at least 80% of the predicted value. Although percentage-predicted values remain useful for describing measurements, the 2022 ERS/ATS interpretive standard advises against using a fixed threshold of 80% predicted as the sole definition of normality.

This is because the expected range varies with age, height, and other characteristics. A value of 78% predicted, for example, may be within the expected range for one person but below the LLN for another. Likewise, a value above 80% predicted does not automatically establish that the measurement is normal. The LLN and, where available, z-scores provide a more individualized assessment. 

Why a fixed FEV1/FVC ratio can be misleading

A similar limitation applies to using a fixed FEV1/FVC ratio of 0.70 to identify airflow obstruction in every patient. Although the Global Initiative for Chronic Obstructive Lung Disease (GOLD) uses a post-bronchodilator ratio below 0.70 as part of its diagnostic criteria for COPD, the ATS/ERS approach to interpreting spirometry generally favors comparing the ratio with its age-appropriate LLN.

The distinction matters because the FEV1/FVC ratio normally changes with age. A fixed cutoff may fail to identify some younger people whose ratios are abnormally low for their age, while classifying some older adults as obstructed even when their ratios remain within the age-appropriate reference range. COPD diagnosis must follow the relevant clinical guideline and take symptoms and exposure history into account. 

Applying reference ranges to spirometry test results

The following hypothetical examples illustrate how reference values guide interpretation. They are educational examples, not diagnostic thresholds for individual patients.

Spirometry finding	Possible interpretation
FEV1, FVC, and FEV1/FVC are within their respective reference ranges	Consistent with normal spirometry, assuming acceptable test quality
FEV1/FVC is below the LLN	Suggests an obstructive pattern
FVC is below the LLN while FEV1/FVC is preserved	Suggests a possible restrictive pattern or another cause of reduced FVC
A result lies close to the LLN	Requires careful interpretation because biological and measurement variability may affect classification

When results are borderline, clinicians should consider the quality and repeatability of the spirometry test, the patient’s symptoms, and the degree to which the measurement differs from the LLN. Additional pulmonary function testing may be necessary when the findings suggest restriction or do not adequately explain the clinical presentation.

In summary, reference equations establish the expected values, while the LLN helps identify measurements that are unusually low relative to a healthy population. Understanding both concepts is essential for interpreting spirometry normal values accurately and avoiding the misclassification that can occur when fixed numerical cutoffs are applied to everyone.

Spirometry Test Procedure and Quality

Accurate Spirometry Normal Values depend not only on the patient’s age, height, and other factors used in reference equations but also on how the spirometry test is performed. A technically poor test can produce misleading forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and FEV1/FVC ratio measurements, making normal lung function appear abnormal or concealing an underlying respiratory problem.

Spirometry is an effort-dependent pulmonary function test. The patient must inhale fully, exhale forcefully, and continue blowing for an adequate duration while following the technician’s instructions. The equipment must also be functioning correctly, and the operator must assess the quality of each attempt before selecting the results for interpretation. The American Thoracic Society (ATS) and European Respiratory Society (ERS) provide standardized procedures for preparing patients, conducting the maneuver, and evaluating the acceptability and repeatability of measurements. 

Quality assurance is important because even small errors can affect the calculated predicted values and the interpretation of spirometry results. For example, if a patient stops exhaling too early, the recorded FVC may be lower than the actual forced vital capacity. This could suggest a restrictive lung pattern even when the incomplete maneuver, rather than a genuine reduction in lung volume, explains the result.

Patient Preparation and Testing Steps

Proper patient preparation helps produce reliable spirometry data and reduces the likelihood that temporary factors or poor technique will affect the findings. Preparation involves reviewing relevant clinical information, checking the spirometer, explaining the procedure, positioning the patient correctly, and coaching the patient through the breathing maneuver.

Preparing the patient before the spirometry test

Before testing begins, the healthcare professional should confirm the patient’s identity and review the reason for the pulmonary function test. Relevant information may include respiratory symptoms, smoking or vaping history, medication use, recent illness, and any conditions that could make forceful breathing difficult or unsafe. The operator should also check for relevant precautions or contraindications according to the facility’s protocol.

The patient’s age, height, and other information required by the selected reference equation should be recorded accurately. Height should generally be measured without shoes, because an incorrect measurement can alter the predicted FEV1 and FVC values. If the patient cannot stand upright, an appropriate alternative estimation method may be used and documented.

Patients should receive clear instructions about activities that may affect test results. The ATS/ERS standard recommends avoiding the following before testing:

• Smoking, vaping, or water-pipe use: Avoid for at least one hour before the test.
• Vigorous exercise: Avoid for at least one hour before testing.
• Intoxicating substances: Avoid for at least eight hours before testing.
• Restrictive clothing: Avoid clothing that significantly limits expansion of the chest or abdomen.

These are standardized recommendations, but the testing facility may provide additional instructions based on the patient’s condition and the purpose of the assessment. 

Medication instructions require particular care. Some spirometry assessments are performed before and after a bronchodilator to evaluate changes in airflow. If the purpose is to measure bronchodilator responsiveness, the clinician may ask the patient to withhold certain inhaled medications for a specified period. The required interval depends on the medication and the testing protocol. Patients should not stop prescribed respiratory medication independently; they should follow the instructions provided by their healthcare professional. When the objective is to assess lung function while taking usual treatment, medication may be continued as directed, with its use documented.

The operator should also explain what the test involves and reassure the patient that several attempts are usually necessary. Repeating a maneuver is a normal part of quality-controlled testing, not necessarily evidence that the patient has performed it incorrectly.

Checking the spirometer and testing environment

The spirometer must be ready for use before the patient begins. The operator should follow the manufacturer’s instructions and applicable laboratory procedures to verify equipment performance, including calibration or calibration verification where required. A clean mouthpiece and an appropriate bacterial or viral filter should be used according to infection-control procedures. Equipment should be checked for leaks, obstruction, and other faults that could compromise measurements.

The patient’s posture is also important. Testing is commonly performed while sitting upright, with the head in a neutral or slightly elevated position. The feet should be supported, and the patient should avoid bending forward or compressing the chest and abdomen. A nose clip is usually applied so that air does not escape through the nose, and the lips must form a tight seal around the mouthpiece.

Maintaining a consistent posture is especially useful when comparing spirometry values across different appointments. Changes in posture can influence measurements slightly, so the position used should be documented when relevant. 

Performing the forced vital capacity maneuver

The forced vital capacity maneuver measures how much air a patient can forcibly exhale after taking the deepest possible breath. It provides the measurements needed to determine FVC and FEV1 and calculate the FEV1/FVC ratio.

The procedure generally follows these steps:

1. Establish a comfortable breathing pattern. The patient places the mouthpiece in the mouth, seals the lips around it, and breathes normally until ready to begin.
2. Inhale fully and rapidly. The patient takes the deepest possible breath, filling the lungs as completely as possible. Incomplete inspiration can reduce the recorded FVC and affect FEV1.
3. Begin expiration without hesitation. Immediately after reaching full inspiration, the patient blows out as hard and as fast as possible. A weak or delayed start may produce an inaccurate FEV1 measurement.
4. Continue exhaling. The patient keeps blowing until the lungs are emptied as completely as possible or the operator determines that an appropriate end-of-expiration criterion has been met. Some patients need more time than others, so the maneuver should not be stopped prematurely.
5. Inhale again when instructed. In spirometers that measure both inspiration and expiration, the patient may be asked to inhale rapidly and fully after completing the forced expiration.
6. Recover and repeat. The patient rests as needed before another attempt. The operator reviews each maneuver and provides specific coaching to improve technique.

The operator should demonstrate the maneuver and use short, direct instructions, such as “Take a deep breath in,” “Blow out hard and fast,” and “Keep going, keep going.” Encouragement should continue throughout expiration because some patients stop too soon when they feel that most of the air has already been expelled. The ATS/ERS standard describes a maximal inspiration, an explosive start to expiration, continued expiration, and—where the equipment and protocol require it—a maximal inspiration afterward. 

How many attempts are required?

A test session generally aims to obtain at least three acceptable FEV1 and three acceptable FVC measurements. These do not necessarily have to come from the same maneuver. The operator compares the best acceptable measurements to determine whether the results are sufficiently repeatable.

For most adults, up to eight forced vital capacity maneuvers is a practical upper limit under the ATS/ERS standard, although the number may vary depending on circumstances. Testing should not continue indefinitely in pursuit of perfect results. Repeated forceful expiration can cause fatigue, dizziness, or discomfort, and the operator should allow recovery time and consider patient safety. Testing in children may require a different approach because their cooperation and ability to complete the maneuver can vary. 

Example: A patient completes three attempts with FVC readings of 3.80 L, 3.86 L, and 3.84 L. These values are close to one another, suggesting good repeatability for FVC. The operator must still assess the shape of the curves and other quality criteria before deciding whether the measurements are acceptable. Close values alone do not guarantee a technically valid test.

The final report should include the best appropriate measurements, relevant quality information, and any limitations that affect confidence in the results. Only then can the FEV1, FVC, and FEV1/FVC ratio be compared meaningfully with spirometry reference values.

Acceptability, Repeatability, and Common Testing Errors

A spirometry test can produce numerical results even when the patient has not performed the maneuver correctly. For this reason, quality assessment is essential before interpreting Spirometry Normal Values or deciding whether the results suggest an obstructive or restrictive pattern.

Three related concepts guide this assessment:

• Acceptability: Whether an individual breathing maneuver meets the technical requirements for a valid measurement.
• Repeatability: Whether the best acceptable measurements within the same test session are sufficiently close to one another.
• Reproducibility: Whether measurements remain reasonably consistent when compared across separate testing sessions, such as appointments on different days.

Acceptability and repeatability are particularly important when determining whether FEV1 and FVC are reliable enough for clinical interpretation. A result may appear abnormal because of the patient’s respiratory condition, but it may also be affected by inadequate effort, premature termination, coughing, or equipment problems. 

Acceptability criteria for spirometry

An acceptable maneuver should begin promptly, involve a forceful and continuous expiration, and continue until an appropriate end-of-expiration criterion is reached. The operator assesses the recorded measurements alongside the flow-volume loop, volume-time curve, and observations made during testing.

Important criteria include:

• A satisfactory start: The patient should begin exhaling forcefully without excessive hesitation. A slow start can make the FEV1 measurement unreliable.
• Adequate initial inspiration: The patient should inhale fully before beginning the forced expiration. Starting with less than a full breath can reduce the measured FVC and affect other values.
• No interfering cough during the first second: A cough during this period can disrupt the measurement of FEV1.
• No significant air leak: The patient must maintain a tight seal around the mouthpiece. Escaping air can lead to inaccurate volume measurements.
• No mouthpiece obstruction: The tongue, teeth, or biting down on the mouthpiece must not block airflow.
• No premature interruption: The patient should continue exhaling until an appropriate end-of-forced-expiration criterion is satisfied.
• No significant glottic closure: Closing the vocal cords during the maneuver can interrupt airflow and invalidate measurements.

Under the ATS/ERS 2019 standard, an end-of-forced-expiration plateau is one indicator of an adequate ending. It is defined as a change in expired volume of no more than 0.025 L during the final second. Other criteria may be used when a plateau cannot be achieved, including an expiration lasting at least 15 seconds or an FVC that meets the specified comparison with the largest previous value. The operator must apply the full criteria rather than relying on duration alone. 

A maneuver can sometimes provide a usable measurement even when it does not meet every criterion for acceptability. For example, a patient may have a cough late in expiration that prevents the FVC measurement from being accepted, while the earlier FEV1 remains usable if the requirements for that measurement have been met. The technician should record and assess such limitations rather than treating every measurement from the maneuver as either fully valid or completely worthless.

Repeatability criteria

Repeatability assesses whether the patient has produced consistent results across separate acceptable maneuvers during the same testing session. It helps establish whether the patient has made a sufficiently maximal and consistent effort.

For patients older than six years, the ATS/ERS 2019 standard generally requires the difference between the two largest acceptable FVC measurements to be no more than 0.150 L (150 mL). The same limit applies to the two largest acceptable FEV1 measurements. For children aged six years or younger, the tolerance is no more than 0.100 L or 10% of the highest value, whichever is greater. 

Consider this example:

Attempt	FEV1	FVC
First	2.90 L	3.70 L
Second	2.95 L	3.76 L
Third	2.93 L	3.73 L

The difference between the two largest FEV1 values is 0.05 L, and the difference between the two largest FVC values is 0.06 L. Both are within the 0.150 L repeatability limit for a patient older than six years.

These measurements demonstrate good repeatability, assuming the individual maneuvers also meet the required quality criteria. The best acceptable FEV1 and FVC values are selected separately; they do not necessarily have to come from the same attempt.

If repeatability is not achieved after three acceptable maneuvers, the operator may ask the patient to repeat the procedure, allowing adequate rest between attempts. The decision to continue depends on the patient’s condition, fatigue, safety, and the quality of the measurements already obtained.

Common testing errors and their effects on results

Poor technique is one of the most important reasons spirometry results may not reflect a patient’s true lung function. Recognizing common errors helps the operator determine whether a low or unusual result represents a physiological abnormality or a problem with test performance.

Common error	Effect on spirometry results	How it can be corrected
Incomplete inspiration	May reduce FVC and affect FEV1.	Coach the patient to inhale fully before blowing out.
Hesitation at the start	Can make FEV1 falsely low or unreliable.	Demonstrate a rapid, forceful start and encourage immediate expiration.
Stopping too early	Can underestimate FVC and mimic a restrictive pattern.	Encourage continued expiration until an appropriate endpoint is reached.
Coughing during the first second	Can distort FEV1.	Allow recovery and repeat the maneuver when appropriate.
Air leaking around the mouthpiece	Can produce inaccurate volume measurements.	Reposition the mouthpiece and reinforce a tight lip seal.
Tongue or teeth obstructing airflow	Can interfere with flow measurements and the recorded curve.	Check mouthpiece position and ensure the airway opening remains clear.
Inconsistent effort	Can produce variable FEV1 and FVC values.	Use consistent instructions, demonstration, and coaching.
Equipment malfunction or incorrect setup	May affect the accuracy of all reported measurements.	Follow equipment quality-assurance procedures and investigate suspected faults.

These errors can have different effects depending on when and how they occur. A cough early in expiration may invalidate FEV1, whereas an interruption later in the maneuver may affect FVC more than FEV1. Likewise, premature termination can produce a low FVC even if the patient’s actual total lung capacity is normal. 

Why poor technique can lead to misinterpretation

The consequences of testing errors become clearer when the measurements are interpreted together.

For example, suppose a patient’s true FVC is 4.0 L, but the patient stops blowing before fully emptying the lungs, producing a recorded FVC of 3.2 L. If the measured FEV1 is 2.8 L, the calculated FEV1/FVC ratio is approximately 87.5%. The ratio may appear preserved, but the artificially reduced FVC could raise concern about a restrictive pattern. The operator must examine the quality of the maneuver before drawing conclusions, and suspected restriction generally requires further assessment with lung-volume measurements, including total lung capacity.

In another example, a patient with possible obstructive lung disease begins exhaling too slowly. The measured FEV1 may be lower than the patient can achieve with a proper forced start, affecting the FEV1/FVC ratio and potentially making airflow obstruction appear more pronounced. Repeating the test with correct coaching may clarify whether the initial result was reliable.

These examples illustrate why Spirometry Normal Values should not be interpreted from isolated numbers alone. The clinician must consider the quality of the maneuver, the repeatability of FEV1 and FVC, the flow-volume curve, the patient’s symptoms, and other clinical information.

When spirometry quality is insufficient

Not every patient can produce a fully acceptable and repeatable test. Severe breathlessness, pain, fatigue, weakness, difficulty understanding instructions, or other clinical limitations may prevent an ideal maneuver. In such cases, the operator should document the limitations and determine whether the available measurements are usable.

A poor-quality test should not automatically be interpreted as evidence of lung disease, nor should an abnormal result be dismissed simply because the maneuver was difficult. Instead, the quality limitations must be considered when deciding how much confidence to place in the findings and whether repeat testing or additional pulmonary function tests are needed.

In summary, reliable spirometry requires acceptable individual maneuvers, repeatable measurements, appropriate equipment checks, and careful coaching. These quality controls help ensure that FEV1, FVC, and the FEV1/FVC ratio provide a meaningful basis for comparing measured lung function with reference values and identifying possible respiratory abnormalities.

Interpreting Spirometry Test Results

Interpreting spirometry test results involves more than checking whether a measurement falls within a stated normal range. The clinician must assess test quality, compare measured lung function with appropriate reference values, identify the pattern formed by the forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio, and consider the findings alongside the patient’s symptoms and medical history.

Spirometry Normal Values are determined by comparing measured results with reference equations appropriate for the individual. The lower limit of normal (LLN), usually corresponding to the fifth percentile of a healthy reference population, helps identify measurements that are unusually low. Z-scores can further indicate how far a result lies from the predicted average.

The 2022 joint technical standard from the American Thoracic Society (ATS) and European Respiratory Society (ERS) emphasizes distinguishing physiological patterns from clinical diagnoses. Spirometry can demonstrate airflow obstruction or suggest a restrictive impairment, but it does not independently establish every underlying disease. For example, an obstructive pattern may occur in asthma or chronic obstructive pulmonary disease (COPD), while a low FVC may reflect restriction, air trapping, or an incomplete maneuver. 

A systematic interpretation generally follows this sequence:

1. Review test quality. Confirm that the measurements are technically acceptable and sufficiently repeatable.
2. Compare measurements with reference values. Assess FEV1, FVC, and the FEV1/FVC ratio against their appropriate lower limits of normal.
3. Identify the spirometric pattern. Determine whether the results are normal, obstructive, suggestive of restriction, or potentially mixed.
4. Assess the degree of impairment. Consider the relevant z-scores and the extent of any abnormality.
5. Integrate the clinical findings. Relate the results to symptoms, examination findings, medication use, and the reason for testing.
6. Determine whether further assessment is needed. Depending on the pattern, this may include bronchodilator testing, measurement of total lung capacity, assessment of gas transfer, or repeat spirometry.

This approach reduces the risk of labeling a patient with lung disease based on a single abnormal number or overlooking an abnormality because one measurement appears normal.

Identifying Normal and Abnormal Spirometry Patterns

A normal spirometry result generally means that both the FEV1/FVC ratio and FVC fall within their expected ranges, with FEV1 also interpreted in relation to its reference range. The flow-volume loop should be consistent with the measured values, and the test must be of adequate quality.

An abnormal result occurs when one or more measurements fall outside the expected range or when the pattern suggests impaired airflow or reduced lung volume. However, the interpretation depends on which measurement is abnormal and how the values relate to one another.

Normal spirometry pattern

A normal pattern is characterized by:

• FEV1 within the expected reference range.
• FVC within the expected reference range.
• FEV1/FVC at or above the lower limit of normal.
• No major technical problem that undermines confidence in the results.

For example, consider a patient with an FEV1 of 3.2 L and an FVC of 4.0 L. The FEV1/FVC ratio is:

\[ \frac{3.2}{4.0}\times100=80\% \]

If the FEV1 and FVC are also within their respective reference ranges, and 80% is above the patient’s LLN for the ratio, these findings are consistent with normal spirometry.

However, an apparently normal result does not exclude every respiratory disease. A patient with intermittent asthma, for example, may have normal lung function between episodes. If symptoms persist despite normal spirometry, further evaluation or testing during symptoms may be appropriate.

Abnormal spirometry pattern

An abnormal result may involve a reduced FEV1, reduced FVC, reduced FEV1/FVC ratio, or a combination of these findings. The pattern helps identify which aspect of respiratory function may be impaired.

Spirometry measurement	Possible interpretation
Reduced FEV1/FVC ratio	Suggests airflow obstruction when below the LLN.
Reduced FVC with a normal or increased ratio	May suggest restriction, but lung volumes are needed to confirm it.
Reduced FEV1, reduced FVC, and reduced ratio	May indicate obstruction with air trapping or a possible mixed impairment.
Reduced FEV1 and FVC with a preserved ratio	May represent a nonspecific pattern, restriction, suboptimal effort, or other physiological problems.
Measurements near the LLN	May require cautious interpretation, particularly when clinical findings and spirometry disagree.

These patterns are guides rather than definitive diagnoses. A low FEV1, for instance, can occur in obstructive disease, restrictive impairment, respiratory muscle weakness, or poor effort. The ratio and FVC help determine which explanation is more plausible. 

Using z-scores and predicted values

Predicted values estimate what might be expected for a person with the characteristics included in the selected reference equation. Results are often reported as absolute measurements, percentages of predicted values, and z-scores.

A percentage of predicted value is calculated by dividing the measured value by the predicted value and multiplying by 100. For example, if a patient’s measured FEV1 is 2.4 L and the predicted FEV1 is 3.0 L, the result is 80% predicted.

Although this calculation is useful for describing lung function, 80% predicted is not a universal threshold for normality. A result at 80% predicted can be within the reference range for one individual but below the LLN for another. Z-scores account for the expected distribution of measurements and are generally preferred in modern interpretive standards for identifying results outside the normal range.

For example, a z-score below approximately −1.645 is below the fifth percentile and therefore below the usual LLN. It should still be interpreted in the context of test quality, biological variability, and clinical findings. 

Why the flow-volume loop matters

The flow-volume loop displays airflow against lung volume during forced expiration and inspiration. Its shape can provide information that is not immediately obvious from the numerical results alone.

• A normal loop usually shows a rapid rise to peak expiratory flow followed by a smooth decline.
• An obstructive pattern may show a reduced peak flow and a concave, or scooped-out, expiratory limb.
• A restrictive pattern may show a smaller overall loop because the volume exhaled is reduced, although the appearance alone cannot confirm restriction.
• Flattening of the inspiratory limb, expiratory limb, or both may raise suspicion of an upper or central airway obstruction.

The loop must be assessed alongside the numerical measurements and technical quality. A poorly performed maneuver can also produce an unusual shape, so an abnormal-looking curve does not automatically indicate disease.

Recognizing Obstructive and Restrictive Lung Patterns

Obstructive and restrictive lung patterns are two major categories used to interpret pulmonary function test results. They describe different physiological problems: obstructive impairment involves difficulty moving air out of the lungs because expiratory airflow is limited, whereas restrictive impairment involves reduced lung expansion and total lung volume.

Distinguishing these patterns is important because they may produce overlapping symptoms, including shortness of breath, cough, and reduced exercise tolerance, but they require different investigations and may have different causes.

Obstructive lung pattern

An obstructive pattern is identified by an FEV1/FVC ratio below the lower limit of normal. It indicates that the volume of air exhaled during the first second is disproportionately low compared with the total volume forcibly exhaled.

Obstruction can occur when the airways narrow because of inflammation, bronchoconstriction, mucus, structural changes, or premature airway collapse during expiration. These changes increase resistance to airflow and slow the rate at which air leaves the lungs.

Conditions associated with an obstructive pattern include:

• Asthma: Airway inflammation and bronchoconstriction can narrow the airways. The degree of obstruction may vary over time and may improve after a bronchodilator.
• Chronic obstructive pulmonary disease (COPD): Persistent airflow obstruction is associated with conditions such as emphysema and chronic bronchitis. Airflow limitation is not always fully reversible.
• Bronchiectasis: Structural damage and widening of the airways can contribute to mucus retention and airflow obstruction.
• Other airway disorders: Depending on their location and severity, airway abnormalities can also impair expiratory flow.

Common spirometry findings include a reduced FEV1/FVC ratio and a reduced FEV1. FVC may be normal or low. In some patients, air becomes trapped in the lungs because the airways do not empty effectively during expiration. This can reduce the measured FVC even when the total lung capacity is normal or increased.

Example: A patient has an FEV1 of 1.8 L and an FVC of 3.0 L.

\[ \frac{1.8}{3.0}\times100=60\% \]

If 60% is below the patient’s LLN, the results indicate an obstructive spirometric pattern. The reduced ratio supports the presence of airflow obstruction, but it does not establish whether the cause is asthma, COPD, or another airway disorder. The clinician must consider the patient’s symptoms, medical history, exposure history, and additional test findings.

A bronchodilator test may help assess whether airflow improves after medication. However, a positive bronchodilator response does not by itself prove asthma, and a limited response does not automatically exclude it.

Restrictive lung pattern

A restrictive ventilatory impairment occurs when the lungs cannot expand to their expected volume. Restriction may arise from disease affecting the lung tissue itself or from conditions outside the lungs that limit expansion.

Possible causes include:

• Interstitial lung diseases, such as pulmonary fibrosis, which can make lung tissue stiff and reduce the volume available for breathing.
• Chest wall abnormalities, which may limit the ability of the chest to expand.
• Neuromuscular disorders, which can weaken the respiratory muscles and impair inspiration.
• Obesity, which can affect respiratory mechanics and reduce some lung volumes, particularly in more severe cases.

A restrictive pattern is suspected on spirometry when FVC is below its LLN while the FEV1/FVC ratio remains normal or increased. FEV1 may also be reduced because the patient is exhaling from a smaller total lung volume.

However, a low FVC alone does not confirm restrictive lung disease. Air trapping, incomplete inspiration, early termination of expiration, and respiratory muscle weakness can also produce a reduced FVC. Restriction is confirmed by demonstrating a total lung capacity (TLC) below its LLN using an appropriate lung-volume measurement. 

Example: A patient has an FEV1 of 2.2 L and an FVC of 2.6 L.

\[ \frac{2.2}{2.6}\times100\approx84.6\% \]

If the ratio is within the patient’s reference range but the FVC is below its LLN, the pattern may suggest restriction. Further testing is needed to determine whether TLC is reduced. If TLC is normal, the low FVC may instead represent a nonspecific pattern or reflect another factor affecting the maneuver.

Mixed obstructive and restrictive pattern

A mixed ventilatory impairment occurs when airflow obstruction and true restriction coexist. Spirometry may show a reduced FEV1/FVC ratio alongside a reduced FVC, but these findings alone cannot confirm that both impairments are present.

The reduced FVC may result from air trapping caused by obstruction rather than a separate restriction. Measuring TLC helps distinguish these possibilities:

• Low FEV1/FVC with normal TLC: Consistent with airflow obstruction without confirmed restriction.
• Low FEV1/FVC with low TLC: Consistent with a mixed obstructive and restrictive impairment.
• Normal FEV1/FVC with low FVC and low TLC: Consistent with a restrictive impairment without spirometric evidence of obstruction.

For example, a patient with COPD may also have pulmonary fibrosis. The COPD can reduce expiratory airflow, while fibrosis can reduce lung expansion. If both the FEV1/FVC ratio and TLC are below their respective LLNs, the findings support a mixed impairment.

The following table summarizes the main differences.

Feature	Obstructive pattern	Restrictive pattern
Primary problem	Limited expiratory airflow	Reduced lung expansion or volume
FEV1	Often reduced	Often reduced
FVC	Normal or reduced	Often reduced
FEV1/FVC ratio	Below LLN	Usually normal or increased
TLC	Normal or increased in some cases	Below LLN
Examples	Asthma, COPD, bronchiectasis	Pulmonary fibrosis, chest wall or neuromuscular disorders
Key confirmation	Spirometric evidence of obstruction, interpreted clinically	Low TLC confirms restriction

When reviewing Spirometry Normal Values, it is therefore important to evaluate the relationship between FEV1 and FVC rather than judging each measurement independently. The ratio helps identify airflow obstruction, while FVC helps determine whether reduced exhaled volume warrants further investigation. TLC is particularly important when a restrictive or mixed pattern is suspected.

Interpreting Borderline and Inconclusive Results

Not all spirometry test results clearly fall into a normal or abnormal category. Some measurements lie close to the lower limit of normal, while others show combinations that do not establish a specific physiological impairment. These findings are described as borderline, indeterminate, or inconclusive, depending on the circumstances.

Borderline results require particular care because lung function varies naturally between individuals and can fluctuate within the same person. Measurement uncertainty, temporary respiratory symptoms, medication use, and testing technique can all influence the findings. A value just below the LLN does not automatically establish clinically significant disease, just as a value just above it does not guarantee the absence of respiratory disease. The ATS/ERS interpretive standard recommends considering this uncertainty alongside clinical expertise. 

Results close to the lower limit of normal

The LLN represents the lower boundary of the expected range for a healthy reference population. Because it is a statistical boundary, some healthy people will naturally have measurements below it. Likewise, a person with respiratory disease may have results that remain within the reference range, especially when the disease is mild, intermittent, or not producing measurable abnormalities at the time of testing.

For example, suppose the FEV1/FVC ratio is slightly below the patient’s LLN. If the test quality is good and the patient has persistent wheezing, breathlessness, or a relevant exposure history, the result may support further investigation for airflow obstruction. If the ratio is only marginally reduced and the patient has no symptoms, the clinician may consider repeat testing, measurement variability, and other clinical information before deciding what the finding means.

A borderline result should be interpreted using the actual reference limits and z-scores rather than relying only on a rounded percentage or a fixed cutoff. This is especially important for people whose expected lung function differs substantially from the population average because of age, height, or other factors included in the selected reference equation.

Normal spirometry despite ongoing symptoms

A normal test does not always explain a patient’s symptoms. Some respiratory conditions fluctuate, and spirometry may be normal when the patient is not experiencing symptoms. Asthma is one example: airway obstruction may be present during an episode but absent between episodes.

If the patient has persistent symptoms despite normal spirometry, the clinician may consider:

• Repeating spirometry when symptoms are present, if appropriate.
• Performing bronchodilator responsiveness testing when indicated.
• Considering bronchial provocation testing if asthma remains suspected and the test is appropriate.
• Reviewing medication use, smoking history, occupational exposures, and other possible causes of symptoms.
• Assessing other aspects of respiratory function, such as lung volumes or gas transfer, when clinically indicated.

A normal spirometry result can make certain abnormalities less likely, but it cannot rule out every respiratory or cardiovascular condition. Further testing should be guided by the clinical question rather than ordered automatically for every normal result. 

Low FVC with a normal FEV1/FVC ratio

One common source of uncertainty is a reduced FVC with a preserved ratio. This pattern may suggest restrictive lung disease, but it does not establish restriction on its own.

Several explanations are possible:

• True restriction: The total lung capacity is reduced because of pulmonary fibrosis, chest wall limitation, neuromuscular weakness, or another cause.
• Air trapping: The patient cannot fully exhale because of airway obstruction, causing the measured FVC to be lower than expected.
• Suboptimal effort: Incomplete inspiration or premature termination of expiration reduces the measured FVC.
• Nonspecific pattern: FEV1 and FVC may be reduced while the ratio remains preserved, but TLC is not reduced.
• Other physiological factors: Body habitus, respiratory muscle function, and other conditions may contribute to the pattern.

For example, a patient has an FEV1 of 2.0 L and an FVC of 2.4 L, giving an FEV1/FVC ratio of approximately 83%. If FVC is below its LLN, the result raises the possibility of restriction. If TLC is subsequently measured and found to be normal, restriction has not been confirmed, and the clinician may investigate a nonspecific pattern or other explanations.

The distinction matters because diagnosing restrictive lung disease solely from a reduced FVC can lead to an inaccurate conclusion. Measurement of TLC is the key step in confirming a restrictive ventilatory impairment. 

Reduced FEV1 and FVC with a low ratio

When both FEV1 and FVC are reduced and the FEV1/FVC ratio is also below the LLN, airflow obstruction is present as a spirometric pattern. However, the reduced FVC raises the question of whether air trapping is present or whether restriction coexists.

The clinician may need lung-volume testing to measure TLC and residual volume (RV). A high RV may indicate air trapping, whereas a low TLC supports a restrictive component. If TLC is normal, the reduced FVC may be explained by obstruction and incomplete emptying rather than true restriction.

For example, a patient with COPD may have a low FEV1/FVC ratio and low FVC because the airways close prematurely during expiration. Another patient with both COPD and pulmonary fibrosis may have the same spirometric pattern but also have a reduced TLC. The spirometry measurements alone cannot reliably distinguish these possibilities.

Poor-quality or inconsistent results

Some findings are inconclusive because the measurements are technically unreliable. This may occur when the patient cannot perform a complete maneuver, coughs during the first second, starts exhaling too slowly, or produces substantially different measurements across attempts.

In such circumstances, the operator should review the flow-volume loops, assess the acceptability of individual maneuvers, and determine whether additional attempts are appropriate. If the results remain unreliable, the limitations should be documented and repeat testing may be necessary.

An automated spirometry report may label a result as normal or abnormal based on its programmed thresholds. However, automated interpretation cannot fully account for every technical limitation or clinical circumstance. The clinician must review the underlying measurements and curves rather than relying on the computer-generated conclusion alone. 

When to repeat testing or investigate further

The next step depends on the reason the results are uncertain.

Finding	Possible next step
Measurements are technically poor	Repeat spirometry with improved coaching or equipment checks.
Ratio is borderline and symptoms suggest obstruction	Consider repeat spirometry or additional assessment for airflow variability.
FVC is low but the ratio is preserved	Measure TLC to determine whether restriction is present.
Both the ratio and FVC are low	Assess lung volumes to distinguish air trapping from a possible mixed impairment.
Spirometry is normal but symptoms persist	Consider other respiratory or non-respiratory causes and targeted testing.
Results differ substantially from previous tests	Review test quality, clinical changes, medication use, and the possibility of genuine lung-function decline.

Changes over time are particularly important when monitoring chronic respiratory disease. A single result may be affected by natural variation or test quality, whereas repeated high-quality measurements can help identify a meaningful trend. Comparisons are most useful when testing procedures, reference equations, and reporting methods are appropriately consistent.

In summary, borderline and inconclusive spirometry results should prompt careful review rather than an immediate diagnosis. By considering test quality, the LLN, z-scores, the relationship between FEV1 and FVC, and the patient’s clinical presentation, healthcare professionals can decide whether the findings are reassuring, suggest a physiological impairment, or require further investigation. Spirometry Normal Values are most useful when interpreted as part of a complete clinical assessment, not as isolated numbers.

Spirometry in Common Respiratory Diseases

Spirometry is an important pulmonary function test used to assess airflow, evaluate respiratory symptoms, and monitor changes in lung function over time. By measuring forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and the FEV1/FVC ratio, healthcare professionals can identify patterns that may be associated with common respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and restrictive lung disorders.

Comparing measured results with appropriate Spirometry Normal Values helps determine whether lung function falls within the expected range. However, spirometry does not identify every respiratory disease by itself. The findings must be considered alongside symptoms, medical history, risk factors, physical examination, and other investigations when indicated.

For example, a patient with wheezing and intermittent shortness of breath may have asthma, while a person with a long history of smoking, persistent cough, and progressive breathlessness may have COPD. Both conditions can cause airflow obstruction, but their clinical features and patterns over time may differ. Similarly, a patient with pulmonary fibrosis may have reduced lung volumes and breathlessness without the same obstructive pattern.

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the ATS/ERS interpretive standards emphasize that spirometry provides objective evidence of physiological impairment, but a diagnosis requires appropriate clinical context.

Asthma and Chronic Obstructive Pulmonary Disease (COPD)

Asthma and COPD are common respiratory diseases associated with airflow obstruction. Although both can cause wheezing, coughing, chest tightness, and difficulty breathing, they differ in their underlying mechanisms, typical clinical patterns, and responses to treatment. Spirometry helps identify airflow limitation and assess whether it changes after administration of a bronchodilator.

Spirometry in asthma

Asthma is a chronic inflammatory airway disease characterized by variable respiratory symptoms and variable expiratory airflow limitation. The airways may become inflamed, narrowed, and more sensitive to triggers such as allergens, respiratory infections, exercise, cold air, smoke, or occupational exposures.

During an asthma episode, bronchoconstriction and airway inflammation can reduce the amount of air exhaled during the first second. As a result, FEV1 may decrease disproportionately to FVC, causing the FEV1/FVC ratio to fall below its expected range.

Common spirometry findings in asthma include:

• A reduced FEV1/FVC ratio during periods of airflow obstruction.
• A reduced FEV1, depending on the severity of the episode.
• Improvement in FEV1 or FVC after administration of a bronchodilator in some patients.
• Normal spirometry between episodes, particularly when symptoms are intermittent or treatment is effective.

A key feature of asthma is that airflow limitation can vary over time. Therefore, a single normal spirometry test does not exclude the condition. If the patient’s symptoms strongly suggest asthma but the initial results are normal, the clinician may repeat spirometry when symptoms are present or consider other appropriate tests to demonstrate variable airflow limitation. 

Understanding bronchodilator responsiveness in asthma

A bronchodilator is a medication that relaxes airway smooth muscle, helping to widen narrowed airways and improve airflow. During bronchodilator responsiveness testing, spirometry is performed before and after the medication is administered according to a standardized protocol.

The clinician compares the pre-bronchodilator and post-bronchodilator measurements to determine whether FEV1 or FVC improves meaningfully. The ATS/ERS interpretive standard uses a change greater than 10% of the predicted value in FEV1 or FVC as the criterion for a significant bronchodilator response in adults and children. This is different from simply calculating a percentage increase from the initial measured value. 

For example, suppose a patient’s predicted FEV1 is 3.0 L. Before receiving a bronchodilator, the measured FEV1 is 2.0 L. After administration, it increases to 2.4 L.

The change is:

\[ 2.4-2.0=0.4\text{ L} \]

As a percentage of the predicted FEV1:

\[ \frac{0.4}{3.0}\times100\approx13.3\% \]

The increase exceeds 10% of the predicted value, meeting the current ATS/ERS criterion for a significant bronchodilator response, assuming the measurements are technically acceptable.

This response supports the presence of variable airflow limitation, which may be consistent with asthma in the appropriate clinical setting. However, it does not independently establish the diagnosis. Some patients with COPD also demonstrate a significant bronchodilator response, while some patients with asthma may not show a significant response during a particular test.

Why asthma may produce normal spirometry values

A patient with asthma may have normal FEV1, FVC, and FEV1/FVC measurements when the airways are relatively open. This can occur between episodes, after treatment, or when the disease is mild. Consequently, interpreting Spirometry Normal Values requires consideration of when the test was performed and whether the patient’s symptoms were present at that time.

For example, a patient who experiences wheezing several times a week may have a normal FEV1/FVC ratio during a routine appointment. If the symptoms are intermittent, the clinician may consider repeat spirometry, peak expiratory flow monitoring, or bronchial provocation testing when appropriate. The choice depends on the patient’s clinical history and the degree of diagnostic uncertainty.

A normal test should therefore be interpreted as evidence that significant airflow obstruction was not demonstrated during that assessment, rather than proof that asthma is absent.

Spirometry in chronic obstructive pulmonary disease (COPD)

COPD is a chronic respiratory condition characterized by persistent airflow obstruction, commonly associated with long-term exposure to tobacco smoke, occupational dusts, indoor air pollution, or other harmful particles and gases. Its major clinical manifestations include emphysema and chronic bronchitis, although these terms describe different aspects of the disease rather than interchangeable diagnoses.

In COPD, structural changes in the airways and lung tissue can reduce airflow and make expiration more difficult. Small airway narrowing, inflammation, mucus production, and loss of elastic recoil may contribute to air trapping and lung hyperinflation.

Typical spirometry findings include:

• A reduced FEV1/FVC ratio.
• A reduced FEV1, with the degree of reduction varying between patients.
• A normal or reduced FVC, depending partly on the extent of air trapping and the patient’s ability to exhale fully.
• Persistent airflow obstruction after bronchodilator administration when COPD is confirmed using the GOLD diagnostic approach.

Unlike the ATS/ERS approach to general interpretation, which emphasizes the lower limit of normal, GOLD retains a post-bronchodilator FEV1/FVC ratio below 0.70 as its spirometric criterion for confirming COPD in a patient with compatible symptoms and risk factors. The ratio must be interpreted with clinical findings, and borderline results may warrant repeat testing or further investigation. 

Example of spirometry findings in COPD

Consider a patient with a long smoking history, persistent cough, sputum production, and gradually worsening breathlessness. After bronchodilator administration, the spirometry results show:

• FEV1: 1.6 L
• FVC: 3.0 L
• FEV1/FVC: approximately 53%

The ratio is calculated as follows:

\[ \frac{1.6}{3.0}\times100\approx53.3\% \]

If the post-bronchodilator ratio remains below 0.70 and the patient has a compatible clinical history, the results support a COPD diagnosis under the GOLD framework. The clinician would also consider the patient’s symptoms, exposure history, exacerbations, and other relevant findings.

The low FEV1 indicates impaired expiratory function, but it should not be used alone to determine the full impact of COPD. Clinical assessment includes other factors, such as breathlessness, exercise tolerance, exacerbation history, and the effect of symptoms on daily activities.

Why pre-bronchodilator and post-bronchodilator results matter

Pre-bronchodilator spirometry measures lung function before administration of a bronchodilator, while post-bronchodilator spirometry measures it afterward. Comparing the two can help determine whether airflow obstruction persists after the medication has had an opportunity to act.

A ratio that is below 0.70 before bronchodilator administration but rises to 0.70 or above afterward does not meet the GOLD spirometric criterion for confirming COPD at that assessment. Conversely, a ratio that remains below 0.70 after bronchodilator administration supports persistent airflow obstruction when the clinical context is compatible.

However, results near the diagnostic threshold can vary between tests. The GOLD Science Committee recommends repeat assessment when results are borderline or inconsistent with the clinical picture. Neither a bronchodilator response nor its absence can reliably distinguish asthma from COPD on its own. 

Comparing asthma and COPD

Feature	Asthma	COPD
Typical symptom pattern	Often variable, with episodes of wheezing, cough, chest tightness, or breathlessness	Often persistent or progressive breathlessness, cough, and sputum production
Airflow obstruction	May vary substantially over time	Often persists after bronchodilator administration
Spirometry between symptomatic periods	May be normal	Often demonstrates persistent obstruction once established, although findings vary
Bronchodilator response	May show a significant improvement	May also show a significant improvement
Diagnostic approach	Symptoms and evidence of variable expiratory airflow limitation	Compatible symptoms and exposure history plus persistent post-bronchodilator airflow obstruction
Additional considerations	Allergy history, triggers, symptom variability, and further testing when necessary	Smoking or other exposure history, exacerbations, symptoms, and assessment of disease impact

These are general patterns, not absolute rules. Some patients have features of both asthma and COPD, and the presence of one condition does not automatically exclude the other. The clinician must integrate spirometry with the wider clinical picture.

When interpreting Spirometry Normal Values in either disease, the key questions are whether airflow obstruction is present, whether it changes after bronchodilator administration, and whether the findings fit the patient’s symptoms and history. The test helps establish the physiological pattern, while the clinical assessment guides diagnosis and treatment decisions.

Restrictive Lung Disease and the Need for Further Testing

Restrictive lung disease refers to conditions in which lung expansion or total lung volume is reduced. Unlike an obstructive pattern, in which expiratory airflow is disproportionately limited, a restrictive impairment is defined by a reduction in total lung capacity (TLC) below its lower limit of normal.

Spirometry can raise suspicion of restriction, but it cannot directly measure TLC. This distinction is important because a low FVC may result from true restriction, air trapping, incomplete inspiration, early termination of expiration, or other physiological and technical factors. The ATS/ERS interpretive standard therefore recommends measuring lung volumes when spirometry suggests a restrictive or mixed pattern. 

How restrictive lung disease affects spirometry

In restrictive disorders, the volume of air the lungs can hold may be reduced. The FEV1 and FVC may both fall because the patient begins the forced expiration with a smaller volume of air available to exhale.

The FEV1/FVC ratio is often preserved or increased because FEV1 and FVC decrease proportionately, although the exact pattern varies with the underlying condition and the presence of other abnormalities.

Potential causes include:

• Interstitial lung diseases: Conditions such as pulmonary fibrosis can make lung tissue stiff, reducing the ability of the lungs to expand.
• Chest wall disorders: Certain skeletal abnormalities can limit chest expansion.
• Neuromuscular conditions: Weakness of the respiratory muscles may impair inspiration and reduce lung volumes.
• Obesity: Increased mechanical loading of the chest and abdomen can affect lung volumes, particularly functional residual capacity and expiratory reserve volume. Obesity does not necessarily cause a restrictive ventilatory impairment in every patient.
• Pleural disorders: Extensive pleural thickening or other pleural abnormalities may restrict lung expansion.

These conditions can produce similar spirometry patterns, so additional assessment is often necessary to identify the underlying cause.

Example of a suspected restrictive pattern

Suppose a patient with progressive breathlessness has the following spirometry results:

• FEV1: 2.1 L
• FVC: 2.5 L
• FEV1/FVC: 84%

The ratio is preserved, but the FVC is below the patient’s LLN. This combination raises suspicion of a restrictive pattern, especially if the flow-volume loop also shows reduced overall volume.

However, the results do not confirm restrictive lung disease. If lung-volume testing demonstrates that TLC is below its LLN, the findings support a restrictive ventilatory impairment. If TLC is normal, restriction has not been established, and the clinician should consider other explanations for the reduced FVC.

Further testing to confirm restriction

Several additional tests may help clarify an abnormal spirometry result. The choice depends on the suspected disease, symptoms, and clinical findings.

1. Total lung capacity measurement

TLC is the total volume of air in the lungs after a maximal inspiration. It is the principal measurement used to confirm or exclude a restrictive ventilatory impairment.

Lung volumes may be measured using body plethysmography or gas-dilution techniques, depending on the clinical setting. Body plethysmography is particularly useful when air trapping is suspected because it can measure gas volume within the thorax that may not be captured accurately by some gas-dilution methods.

A TLC below the LLN supports restriction. A normal TLC indicates that a low FVC on spirometry does not, by itself, establish a restrictive impairment.

2. Diffusing capacity of the lung for carbon monoxide (DLCO)

DLCO assesses how effectively gas transfers from the air sacs into the blood. It may help investigate the cause of breathlessness or an abnormal pulmonary function test.

A reduced DLCO can occur in interstitial lung disease, emphysema, pulmonary vascular disease, anemia, and other conditions. Its interpretation requires appropriate adjustments and clinical context, because a low value is not specific to one disease.

For example, a patient with suspected pulmonary fibrosis may have reduced FVC, a preserved FEV1/FVC ratio, reduced TLC, and reduced DLCO. Together, these findings support further evaluation for an interstitial lung disorder, although imaging and other clinical investigations may be required to establish the diagnosis.

3. Chest imaging

Chest X-ray or computed tomography (CT) may be indicated when symptoms, examination findings, or pulmonary function results suggest structural lung disease. High-resolution CT can be particularly useful when interstitial lung disease or pulmonary fibrosis is suspected.

Imaging does not replace spirometry or lung-volume measurement. Instead, it provides structural information that complements physiological testing.

4. Respiratory muscle assessment

When neuromuscular weakness is suspected, the clinician may consider respiratory muscle strength testing and other targeted assessments. Reduced lung volumes may arise because the patient cannot generate sufficient inspiratory force rather than because the lung tissue itself is stiff.

The appropriate investigations depend on the suspected cause and should be selected by the treating clinician. 

Distinguishing restriction from air trapping

One important reason to perform further testing is that obstruction and restriction can produce overlapping spirometry results.

In obstructive disease, narrowed airways may prevent complete expiration, leaving excess air trapped in the lungs. This can lower the measured FVC even when TLC is normal or increased. In restrictive disease, TLC is reduced because the lungs cannot expand to their expected volume.

For example, two patients may both have a low FVC and a reduced FEV1. The first patient may have COPD with substantial air trapping and a normal or increased TLC. The second may have COPD combined with pulmonary fibrosis, producing both a low FEV1/FVC ratio and a reduced TLC. Lung-volume testing helps distinguish obstruction alone from a mixed obstructive and restrictive impairment. 

When further testing is warranted

Additional investigations may be appropriate when:

• FVC is below the LLN while the FEV1/FVC ratio is preserved.
• Both the FEV1/FVC ratio and FVC are reduced, raising concern about a mixed impairment.
• Spirometry findings do not adequately explain persistent breathlessness or exercise intolerance.
• The results are inconsistent with the patient’s history, symptoms, or physical examination.
• A suspected restrictive lung disease requires confirmation and investigation of its cause.
• Spirometry results are borderline, technically limited, or inconsistent across assessments.

The decision should be individualized rather than based on a single abnormal measurement. Some patients may need repeat spirometry, while others may require TLC measurement, DLCO testing, imaging, or targeted investigations.

In summary, spirometry helps identify patterns associated with asthma, COPD, and possible restrictive lung disease. The interpretation of Spirometry Normal Values should account for the relationship between FEV1, FVC, and the FEV1/FVC ratio, as well as bronchodilator response and test quality. When restriction or a mixed impairment is suspected, measuring TLC is particularly important because spirometry alone cannot confirm reduced total lung capacity.

Factors Affecting Spirometry Values and Test Accuracy

Spirometry values are influenced by a combination of individual characteristics, respiratory health, patient effort, testing conditions, and equipment performance. Understanding these factors is essential when evaluating Spirometry Normal Values, because a measurement that appears unusually low or high may reflect a genuine change in lung function, normal biological variation, or an error during testing.

The forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio must be interpreted in relation to appropriate reference values and the quality of the spirometry test. The American Thoracic Society (ATS) and European Respiratory Society (ERS) emphasize that interpretation should begin with a review of test quality before clinicians classify a result as normal or abnormal. 

Age, Height, and Biological Sex

Age, height, and biological sex are important factors in the reference equations used to calculate predicted spirometry values. These characteristics help establish the range of lung function expected in a healthy person and allow measured results to be interpreted more meaningfully.

Age: Lung function changes throughout life. During childhood and adolescence, lung volume increases as the lungs, chest, and body grow. In adulthood, lung function may remain relatively stable for a period before gradually declining with age. These changes mean that the same FEV1 or FVC measurement may have different implications for a young adult and an older adult.

For example, an FEV1 of 2.5 L may be within the expected range for one person but below the LLN for another, depending on age, height, and the reference equation used. Age-related changes also affect the FEV1/FVC ratio, which is one reason a single fixed ratio should not replace appropriate reference limits for general spirometry interpretation.

Height: Taller individuals generally have larger lung volumes than shorter individuals, although body proportions and other factors also influence lung size. Incorrect height measurements can therefore affect predicted FEV1 and FVC values and lead to misleading interpretations.

For instance, if a patient’s height is entered incorrectly as 165 cm rather than the measured 175 cm, the spirometer may calculate predicted values that are too low. The patient’s measured lung function could then appear more normal than it should when compared with the incorrect reference values.

Height should be measured without shoes using an appropriate technique. If a patient cannot stand, the testing team may use an appropriate alternative estimation method and document it.

Biological sex: Reference equations account for average differences in lung function associated with biological sex, even after accounting for height. Using incorrect demographic information can therefore alter predicted values and the interpretation of the FEV1, FVC, and FEV1/FVC ratio.

The reference equation used should be documented in the pulmonary function report. Current interpretive standards also emphasize careful consideration of how reference equations are selected and applied, including the limitations and uncertainties associated with different reference populations. 

Respiratory Conditions and Underlying Lung Disease

A person’s respiratory health directly influences spirometry values. Diseases that narrow the airways may reduce expiratory airflow, while conditions that limit lung expansion may reduce the volume of air that can be exhaled.

In obstructive lung disease, such as asthma or chronic obstructive pulmonary disease (COPD), airway narrowing or loss of elastic recoil can reduce FEV1 disproportionately to FVC. This may lower the FEV1/FVC ratio below its lower limit of normal.

In restrictive lung disease, such as pulmonary fibrosis, the lungs may become stiff or unable to expand fully. FEV1 and FVC may both decrease, while the FEV1/FVC ratio remains normal or increases. A low FVC alone does not confirm restriction; total lung capacity (TLC) must be measured to establish whether lung volume is genuinely reduced.

Other respiratory factors can also affect results:

• Respiratory infections: An acute infection may temporarily worsen coughing, airway inflammation, or breathing difficulty and affect test performance.
• Excess mucus production: Secretions may contribute to airflow obstruction or interfere with a maneuver.
• Airway inflammation: Inflammatory changes can narrow the airways and reduce expiratory flow.
• Respiratory muscle weakness: Weakness can limit the ability to inhale fully or exhale forcefully.
• Air trapping: Incomplete emptying of the lungs can reduce the measured FVC despite normal or increased TLC.

For example, a patient with an asthma exacerbation may have a reduced FEV1 and FEV1/FVC ratio during symptoms but show improved values after treatment. A patient with pulmonary fibrosis may have a low FVC and preserved ratio, requiring lung-volume testing to determine whether restriction is present.

These examples demonstrate why spirometry results should be interpreted alongside the patient’s symptoms, medical history, examination findings, and relevant investigations rather than being used as a standalone diagnosis. 

Smoking, Environmental Exposures, and Lifestyle Factors

Smoking and exposure to airborne irritants can influence both long-term lung health and the results of an individual spirometry test.

Smoking and vaping: Tobacco smoke contains substances that irritate the airways and contribute to inflammation, mucus production, and progressive lung damage. Long-term smoking is a major risk factor for COPD, which may produce persistent airflow obstruction. Vaping and other inhaled exposures can also affect respiratory symptoms and may influence test performance.

Smoking shortly before a spirometry test may cause acute changes in airway function. The ATS/ERS standard recommends avoiding smoking, vaping, and water-pipe use for at least one hour before testing. This preparation interval helps reduce immediate effects but does not reverse the consequences of chronic exposure. 

Occupational and environmental exposures: Dust, chemical fumes, smoke, and other airborne irritants may contribute to respiratory symptoms or chronic disease. Workers exposed to these substances may require spirometry as part of an occupational health program. Serial measurements can help identify changes in lung function over time, provided testing is performed consistently and interpreted appropriately.

Physical activity: Vigorous exercise shortly before testing can affect some patients, particularly those who experience exercise-induced bronchoconstriction. The ATS/ERS standard recommends avoiding vigorous exercise for at least one hour before testing.

Clothing and body positioning: Tight clothing around the chest or abdomen may restrict full expansion and affect performance. A slouched posture may also interfere with a full inspiration or forceful expiration. Testing should therefore be conducted with appropriate positioning and clothing that allows comfortable breathing.

Lifestyle and exposure information can help explain an unexpected result, but these factors should not be assumed to account for an abnormal measurement without reviewing the quality of the test and the wider clinical context.

Medication Use and Bronchodilator Effects

Medication use can affect spirometry results, particularly when the purpose of testing is to assess airflow obstruction or bronchodilator responsiveness.

Bronchodilators relax airway smooth muscle and can improve expiratory airflow in people with reversible or partially reversible airway narrowing. Other respiratory medications may reduce airway inflammation or improve symptom control over time.

When a spirometry test is intended to assess bronchodilator responsiveness, the clinician may provide specific instructions about withholding certain medications before testing. The recommended interval depends on the drug, its duration of action, and the purpose of the assessment. Patients should never stop prescribed medication independently; they should follow the instructions of the healthcare professional conducting the test.

For example, a patient with asthma may have a higher FEV1 after taking a prescribed bronchodilator than before treatment. If the medication was taken shortly before a test intended to measure untreated airflow limitation, the initial degree of obstruction may be less apparent.

The report should document relevant medication use and whether the measurements were obtained before or after bronchodilator administration. This information is important when comparing results between visits or interpreting changes in lung function.

Patient Effort, Technique, and Cooperation

Spirometry is an effort-dependent test. The patient must inhale fully and then exhale as forcefully and continuously as possible. Inadequate effort can cause the measured values to differ from the person’s actual respiratory capacity.

Common technique-related factors include:

• Incomplete inspiration: Starting the maneuver without filling the lungs fully can reduce FVC and may affect FEV1.
• Slow or hesitant expiration: A delayed or weak start can reduce the measured FEV1.
• Premature termination: Stopping too early can produce an artificially low FVC.
• Coughing: A cough during the first second of expiration can invalidate the FEV1 measurement.
• Air leakage: A poor seal around the mouthpiece may cause inaccurate volume measurements.
• Airway obstruction by the mouthpiece: Incorrect positioning of the tongue or teeth can interfere with airflow.
• Fatigue or discomfort: Repeated forceful maneuvers may become more difficult if the patient is tired or uncomfortable.

The operator should provide clear instructions, demonstrate the maneuver, encourage a rapid start, and assess the recorded curves. Several attempts are usually required to establish whether the results are acceptable and repeatable.

For example, if a patient records an FVC of 2.8 L on the first attempt but achieves 3.4 L after receiving better coaching, the initial result may have been affected by incomplete inspiration or early termination. The operator should assess the quality of both maneuvers before deciding which measurements are suitable for reporting.

Poor-quality testing can lead to false conclusions about lung function. For this reason, a numerical result should not be considered reliable simply because the spirometer has displayed it. 

Spirometer Calibration, Equipment, and Testing Environment

Accurate spirometry depends on equipment that measures airflow or volume correctly. Problems with the spirometer, sensors, filters, software, or testing setup can affect the reported FEV1 and FVC values.

Equipment quality assurance includes following manufacturer instructions, conducting the required calibration verification, maintaining service records, and repeating quality checks after relevant repairs, changes, or relocation. The ATS/ERS standard describes daily calibration verification for spirometry systems using appropriate low, medium, and high flows, with corrective action required when the verification fails. 

Factors that can affect equipment accuracy include:

• Calibration or verification errors: Incorrect measurement performance can systematically overestimate or underestimate values.
• Air leaks or obstructions: These may interfere with the measured airflow or volume.
• Filter or mouthpiece problems: Incorrect installation or obstruction can affect airflow.
• Temperature and environmental conditions: Spirometry systems must account for the physical properties of air, including temperature and humidity, according to the device’s specifications.
• Software or reference-equation settings: Incorrect demographic entries or an inappropriate reference equation can produce misleading predicted values even when the raw measurement is accurate.
• Inconsistent equipment or procedures: Differences between devices or testing protocols may complicate comparisons across appointments.

For example, if a spirometer systematically underestimates FVC, the results may suggest a low FVC or an apparent restrictive pattern. If the patient’s effort and test quality are satisfactory but the readings remain unexpected, the operator should check equipment performance and other potential sources of error.

The testing environment should also support consistent performance. Patients need clear instructions, sufficient space to sit or stand safely as appropriate, and time to rest between maneuvers. Infection-control procedures should be followed for mouthpieces, filters, and reusable equipment.

Reference Equations and Interpretation Methods

A measurement can be technically accurate yet incorrectly classified if the wrong reference equation or interpretation method is used.

Predicted FEV1 and FVC values depend on the reference equation selected, which incorporates characteristics such as age, height, and biological sex. The expected range is then used to assess whether the measured values are unusually low. The reference equation and its source should be identified in the report.

The Global Lung Function Initiative (GLI) has developed widely used spirometry reference equations. The 2022 GLI equations provide race-neutral spirometric reference values, and current ATS/ERS interpretive guidance emphasizes appropriate equation selection and careful consideration of uncertainty in interpreting lung function. Laboratories should follow their applicable standards and document the equations used. 

Two interpretation errors are particularly important:

Using 80% predicted as a universal definition of normal. A measurement at 80% of predicted does not necessarily fall within the normal range for every individual. The lower limit of normal and z-score provide a more individualized assessment.

Using a fixed FEV1/FVC ratio for every purpose. The ATS/ERS approach to general interpretation emphasizes the LLN rather than a universal fixed ratio. GOLD uses a post-bronchodilator FEV1/FVC ratio below 0.70 as its spirometric criterion for COPD in an appropriate clinical context. These approaches serve different purposes and should not be treated as interchangeable.

For example, an older adult may have an FEV1/FVC ratio below 0.70 but above the age-appropriate LLN. The result may meet the fixed-ratio threshold used in the GOLD framework, but the difference between the two interpretation methods requires careful consideration of symptoms, exposure history, and repeat testing where indicated.

Changes in reference equations can also affect comparisons over time. If a laboratory changes its reference source, a patient’s percentage of predicted value or z-score may change even when the measured FEV1 and FVC remain identical. This is why the reference method must be documented and trends interpreted carefully. 

Biological Variability and Changes Over Time

Spirometry measurements can vary naturally within the same individual. Respiratory symptoms, recent illness, medication effects, fatigue, and differences in effort may cause small changes between tests. Consequently, a single change in FEV1 or FVC does not always represent a meaningful deterioration or improvement in lung function.

When monitoring chronic respiratory disease, clinicians compare current measurements with previous high-quality results. The interpretation should consider the size of the change, the time interval between tests, the quality of each session, and whether the change corresponds with symptoms or treatment.

For example, a patient with COPD may have a slightly lower FEV1 at one appointment than at the previous visit. If the latest test was technically poor because the patient was coughing or could not complete expiration, the difference may not reflect genuine disease progression. Repeating the test under appropriate conditions may help clarify the finding.

By contrast, a sustained decline across multiple high-quality tests, especially when accompanied by worsening breathlessness or reduced exercise tolerance, may warrant further clinical evaluation.

In summary, reliable spirometry interpretation requires consideration of patient characteristics, respiratory disease, medication use, environmental exposures, effort, equipment performance, and the reference equations used. These factors help explain why Spirometry Normal Values must be interpreted alongside test quality and clinical findings rather than as isolated numerical cutoffs. Proper preparation, standardized procedures, accurate demographic information, and consistent quality control make spirometry more useful for assessing lung function and identifying meaningful changes over time.

Clinical Applications, Limitations, and Safety Considerations

Spirometry is widely used to assess lung function, investigate respiratory symptoms, support the diagnosis of airflow obstruction, and monitor changes in respiratory health. By measuring forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and the FEV1/FVC ratio, healthcare professionals can identify patterns that suggest impaired airflow or possible restriction.

Comparing these measurements with appropriate Spirometry Normal Values helps determine whether lung function falls within the expected range for an individual. However, spirometry is not a standalone diagnostic tool. Its findings must be interpreted alongside the patient’s symptoms, medical history, physical examination, exposure history, and other investigations when necessary. The American Thoracic Society (ATS) and European Respiratory Society (ERS) emphasize that pulmonary function test results should be interpreted with consideration of measurement uncertainty, biological variability, and the overall clinical picture.

Clinical Applications of Spirometry

1. Evaluating respiratory symptoms

One of the most common applications of spirometry is investigating symptoms that may indicate impaired respiratory function. These include persistent cough, wheezing, shortness of breath, chest tightness, and reduced exercise tolerance.

For example, a patient who experiences breathlessness when climbing stairs may undergo a spirometry test to determine whether airflow obstruction is present. A reduced FEV1/FVC ratio may suggest an obstructive pattern, prompting further assessment for asthma, COPD, or another airway disorder.

Conversely, if the ratio is preserved but FVC is reduced, the clinician may investigate possible restriction or other causes of reduced measured lung volume. If spirometry is normal despite persistent symptoms, further testing may be appropriate depending on the suspected condition.

2. Supporting the diagnosis of respiratory disease

Spirometry provides objective measurements that help distinguish different patterns of impaired lung function.

• Asthma: Spirometry may demonstrate variable airflow obstruction, and bronchodilator responsiveness testing can help identify changes in expiratory airflow.
• Chronic obstructive pulmonary disease (COPD): Post-bronchodilator spirometry is used to establish persistent airflow obstruction in a patient with compatible symptoms and risk factors.
• Possible restrictive lung disease: A reduced FVC with a preserved FEV1/FVC ratio may raise suspicion of restriction, although total lung capacity (TLC) must be measured to confirm it.
• Other respiratory disorders: Spirometry may contribute to the assessment of bronchiectasis and other conditions that affect airflow or respiratory function.

Spirometry helps identify the physiological pattern, but it does not always establish the specific cause. For instance, a low FEV1/FVC ratio indicates airflow obstruction but cannot independently determine whether the underlying condition is asthma or COPD. 

3. Monitoring disease progression

Repeated spirometry can help clinicians assess changes in lung function over time. This is particularly useful for people with chronic respiratory disease, including COPD, asthma, and selected interstitial lung disorders.

For example, a patient with COPD may undergo periodic testing to determine whether FEV1 has declined compared with previous high-quality measurements. A sustained change may prompt a review of symptoms, treatment effectiveness, smoking or occupational exposures, and the need for additional investigations.

Changes must be interpreted carefully because a small difference between two measurements may reflect normal biological variation or differences in test quality rather than genuine disease progression.

4. Assessing response to treatment

Spirometry can help evaluate whether respiratory function changes following treatment. In asthma, bronchodilator responsiveness testing may demonstrate an improvement in FEV1 or FVC after administration of a bronchodilator. In COPD, repeated measurements may help assess lung function alongside changes in symptoms and exercise tolerance.

For example, if a patient with asthma has improved FEV1 after bronchodilator administration, the result supports the presence of reversible airflow limitation. However, the response does not establish asthma by itself, because patients with other obstructive diseases may also demonstrate improvement.

Treatment effectiveness should not be judged by spirometry alone. Symptoms, exacerbations, medication use, adverse effects, and the patient’s daily functioning are also important.

5. Occupational health and exposure monitoring

Spirometry may be used in occupational health programs to assess respiratory function in people exposed to dust, fumes, chemical vapors, or other airborne hazards. Baseline measurements can be compared with later results to identify potentially important changes.

For example, a worker exposed to industrial dust may have spirometry performed at the beginning of employment and at scheduled intervals afterward. A consistent decline in lung function may lead to further assessment of workplace exposure, respiratory protection, and possible occupational lung disease.

Such programs depend on standardized testing and appropriate interpretation. A change in spirometry does not automatically prove that a workplace exposure caused the impairment, but it can provide an important signal for further investigation. 

6. Preoperative assessment and other clinical uses

Spirometry may be considered when respiratory symptoms or known lung disease are relevant to the planning of selected surgical procedures. The results can contribute to an assessment of respiratory function and perioperative risk.

However, spirometry is not required routinely before every operation. Its usefulness depends on the patient’s symptoms, medical history, planned procedure, and whether the result is likely to change clinical management.

Other applications include pulmonary rehabilitation assessment, selected disability evaluations, clinical research, epidemiological studies, and monitoring people receiving treatments that may affect lung function.

Limitations of Spirometry

Although spirometry is a valuable pulmonary function test, several limitations affect how its results should be interpreted.

Spirometry does not measure every aspect of lung function

Spirometry measures the volume of air exhaled and the rate at which it is expelled during a forced maneuver. It does not directly measure all lung volumes or determine how effectively oxygen crosses from the lungs into the bloodstream.

For example, FVC may be reduced in a patient with suspected restrictive lung disease, but spirometry cannot confirm that total lung capacity is low. A lung-volume test is required to establish restriction. Similarly, a patient may have impaired gas transfer despite relatively preserved spirometry, making a diffusing-capacity test useful when clinically indicated.

Normal results do not exclude all respiratory diseases

A patient may have normal spirometry between episodes of asthma or during a period when treatment is controlling airflow limitation. Some early respiratory conditions may also produce symptoms before spirometry becomes clearly abnormal.

For this reason, normal results should be interpreted according to the clinical question. Persistent breathlessness, recurrent wheezing, or unexplained respiratory symptoms may warrant further assessment even when spirometry falls within the expected range.

Results depend on patient effort and test quality

Spirometry requires a full inspiration followed by a rapid, forceful, sustained expiration. Patients who cannot understand the instructions, have severe discomfort, experience fatigue, or cannot complete the maneuver may produce unreliable measurements.

Poor effort may reduce FEV1 or FVC and lead to an incorrect interpretation. Even when the spirometer generates a report, the operator must review the flow-volume curves, acceptability, and repeatability of the measurements.

Reference values are estimates, not absolute boundaries between health and disease

Predicted values and the lower limit of normal (LLN) are derived from reference equations. They help determine whether a measurement is unusual for an individual, but they cannot independently establish whether the person has a disease.

A result slightly below the LLN may occur in someone without clinically significant respiratory disease, while a person with symptoms may have measurements within the reference range. Clinicians should consider the degree of abnormality, the quality of the test, biological variation, and other findings rather than relying on one cutoff. 

Spirometry cannot always distinguish between different diseases

Different conditions can produce similar spirometric patterns. A reduced FEV1/FVC ratio may occur in asthma, COPD, or other obstructive disorders. A low FVC with a preserved ratio may reflect true restriction, air trapping, suboptimal effort, or a nonspecific pattern.

Additional tests may be necessary to clarify the findings. These can include lung-volume measurements, diffusing capacity, imaging, bronchial provocation testing, or other investigations selected according to the clinical presentation.

Safety Considerations During Spirometry

Spirometry is generally a low-risk procedure, but the forced breathing maneuver can temporarily increase pressure within the chest, abdomen, and head. It can also increase cardiovascular demand. These effects are usually well tolerated, but caution is needed for patients whose medical conditions could be affected by the strain of forced expiration.

The ATS/ERS standard identifies several relative contraindications that require an individualized assessment of risk and benefit. They do not automatically prohibit testing in every circumstance. The clinician ordering the test must consider the patient’s condition, the reason for testing, and whether the test can be performed safely in the available setting. 

Conditions requiring additional caution

Examples of circumstances that may require delaying spirometry, modifying the testing plan, or conducting it in a specialist setting include:

• Recent acute myocardial infarction or an unstable cardiovascular condition.
• Significant arrhythmias, severe uncontrolled blood pressure abnormalities, or decompensated heart failure.
• Uncontrolled pulmonary hypertension or an unstable pulmonary embolism.
• A pneumothorax or recent thoracic or abdominal surgery.
• Recent brain or eye surgery, certain cerebral vascular conditions, or a recent concussion with ongoing symptoms.
• Recent sinus or middle-ear surgery or infection.
• Late-term pregnancy, when the increased physical strain requires consideration.
• Active or suspected transmissible respiratory infections, including tuberculosis, which also raise infection-control concerns.

The relevance of each condition depends on its severity, timing, and the clinical circumstances. Testing may be appropriate after an individualized assessment or in a pulmonary function laboratory with experienced staff and access to appropriate medical support.

Recognizing discomfort and adverse reactions

Repeated forceful expiration can cause temporary coughing, breathlessness, light-headedness, fatigue, or dizziness. Some patients may experience fainting or chest discomfort. The operator should observe the patient throughout the test and allow rest between maneuvers.

Testing should be stopped if the patient develops significant pain, marked distress, or other concerning symptoms. If an adverse event occurs, the operator should follow the facility’s clinical response procedures rather than continuing simply to obtain additional measurements.

For example, if a patient becomes markedly dizzy after several forced expirations, the operator should stop the maneuver, ensure the patient is safe, and assess the symptoms according to clinical protocol. Further testing should only be considered after the patient’s condition has been reviewed.

Infection prevention and equipment hygiene

Because spirometry involves breathing through a mouthpiece, infection prevention is essential. Appropriate filters, mouthpieces, cleaning procedures, and equipment handling practices should be used according to manufacturer instructions and facility protocols.

When a patient has a suspected or confirmed transmissible respiratory infection, the testing team should assess whether the test can be postponed or whether specific precautions and an appropriate setting are needed. Infection-control decisions should follow current local policies and applicable respiratory testing guidance.

Ensuring safe and reliable results

Safety and accuracy are closely related. A patient who is uncomfortable, fatigued, or unable to perform the maneuver safely may not produce reliable measurements. The operator should balance the need for acceptable and repeatable results against the patient’s ability to tolerate further attempts.

Quality assurance also requires appropriate equipment checks, trained operators, clear instructions, and accurate recording of relevant clinical information. If a test is incomplete or technically limited, this should be documented so that the findings are not interpreted with more certainty than the evidence supports.

In conclusion, spirometry has important applications in investigating respiratory symptoms, assessing airflow obstruction, monitoring chronic lung disease, and evaluating response to treatment. Its limitations mean that Spirometry Normal Values must be interpreted in conjunction with clinical findings and, when necessary, additional pulmonary function tests. Appropriate patient selection, infection prevention, awareness of relative contraindications, and careful monitoring help ensure that spirometry is performed safely and that its results provide meaningful information about lung function.

Conclusion

Understanding spirometry normal values is essential for evaluating lung function, recognizing respiratory abnormalities, and supporting the diagnosis and management of pulmonary disease. Measurements such as forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and the FEV1/FVC ratio provide important information about the amount of air a person can exhale and how quickly the air moves through the airways. However, these values must be interpreted in relation to appropriate reference equations, the lower limit of normal, and individual characteristics such as age and height rather than relying on a single universal normal range.

Accurate interpretation of spirometry results also depends on proper patient preparation, correct testing technique, and acceptable, repeatable measurements. Although abnormal spirometry values may suggest obstructive lung disease, including asthma and chronic obstructive pulmonary disease (COPD), or raise suspicion of a restrictive lung pattern, spirometry alone cannot confirm every respiratory diagnosis. Additional pulmonary function tests, clinical assessments, and diagnostic investigations may be necessary to establish the underlying cause.

Recognizing the meaning and limitations of spirometry normal values helps healthcare professionals distinguish expected variations in lung function from potentially significant abnormalities. By combining reliable spirometry data with symptoms, medical history, physical examination findings, and other relevant investigations, clinicians can make better-informed decisions about diagnosis, treatment, and follow-up.

Frequently Asked Questions

1. What are the normal values of spirometry?

Normal spirometry values depend on factors such as age, height, and the reference equations used. Generally, an FEV1/FVC ratio at or above the lower limit of normal and FEV1 and FVC values within their expected reference ranges suggest normal lung function. Values around 80% of predicted are often used as a rough guide, but the lower limit of normal is preferred over a fixed percentage to identify abnormalities accurately.

2. What is the best treatment for restrictive lung disease?

The best treatment depends on the underlying cause. Options may include treating inflammation or an underlying disease, medications for specific conditions, oxygen therapy when indicated, pulmonary rehabilitation, and management of associated conditions. Some cases require specialist care. Treatment should be guided by a healthcare professional because restrictive lung disease has several possible causes.

3. How do I read my spirometry results?

Start by reviewing three measurements: FEV1, FVC, and the FEV1/FVC ratio. Compare them with the predicted values and, especially, the lower limit of normal. A low FEV1/FVC ratio may indicate an obstructive pattern, while a low FVC with a preserved ratio may suggest restriction, which requires confirmation with total lung capacity testing. Test quality and clinical symptoms also affect interpretation.

4. Can you live with lung disease?

Yes. Many people live for years with lung diseases such as asthma, COPD, and certain restrictive lung conditions. Outcomes depend on the type and severity of the disease, overall health, and response to treatment. Appropriate medication, avoiding smoke and other harmful exposures, vaccinations, pulmonary rehabilitation, and regular medical follow-up can help manage symptoms and maintain quality of life.